CAMK2G
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A4FU28 | S138 | Sugiyama | CTAGE9 | EKAAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKS |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00488 | S124 | Sugiyama | ZNF593 ZT86 | RAAGMGSYVPPRRLAVPTEVsTEVPEMDtst__________ |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O00488 | S98 | Sugiyama | ZNF593 ZT86 | THFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRLA |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O14618 | S197 | Sugiyama | CCS | GRAIFRMEDEQLKVWDVIGRsLIIDEGEDDLGRGGHPLSKI |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15212 | T38 | Sugiyama | PFDN6 HKE2 PFD6 | QLQKDLSKSMSGRQKLEAQLtENNIVKEELALLDGsNVVFK |
| O15460 | S531 | Sugiyama | P4HA2 UNQ290/PRO330 | KWVSNKWFHERGQEFLRPCGstEVD________________ |
| O43164 | S253 | Sugiyama | PJA2 KIAA0438 RNF131 | LDsVPLVKssAGDTEFVHQNsQEIQRSSQDEMVSTKQQNNT |
| O43290 | S521 | Sugiyama | SART1 | KQLEKGRRLRQLQQLQQLRDsGEKVVEIVKKLESRQRGWEE |
| O43399 | S166 | Sugiyama | TPD52L2 | tVGsAIsRKLGDMRNsAtFKsFEDRVGtIKSKVVGDRENGs |
| O43399 | T163 | Sugiyama | TPD52L2 | ALstVGsAIsRKLGDMRNsAtFKsFEDRVGtIKSKVVGDRE |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60266 | S1076 | SIGNOR|iPTMNet | ADCY3 KIAA0511 | ARKPHYDIWGNTVNVASRMEsTGVMGNIQVVEETQVILREY |
| O60282 | S176 | Sugiyama | KIF5C KIAA0531 NKHC2 | VHEDKNRVPYVKGCTERFVSsPEEVMDVIDEGKANRHVAVT |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60343 | S591 | Sugiyama | TBC1D4 AS160 KIAA0603 | LENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGDsPP |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | S190 | Sugiyama | EIF5B IF2 KIAA0741 | NsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGP |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75128 | S1171 | Sugiyama | COBL KIAA0633 | SALLAAIRGHSGTCSLRKVAsSAsEELQSFRDAALSAQGSE |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O76070 | S9 | Sugiyama | SNCG BCSG1 PERSYN PRSN | ____________MDVFKKGFsIAKEGVVGAVEKTKQGVTEA |
| O94761 | S27 | Sugiyama | RECQL4 RECQ4 | VRERLQAWERAFRRQRGRRPsQDDVEAAPEETRALYREYRT |
| O94992 | S268 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EDGGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELI |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95071 | S327 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | LLRERESVLRLRERRWLDGAsFDNERGSTSKEGEPNLDKKN |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95180 | S1198 | PSP | CACNA1H | EAEDGRAAPGPRATPLRRAEsLDPRPLRPAALPPTKCRDRD |
| O95197 | S316 | Sugiyama | RTN3 ASYIP NSPL2 | PLRNKEAGRYPMSALLSRQFsHtNAALEEVSRCVNDMHNFT |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95425 | S914 | Sugiyama | SVIL | LRTKPPLDHNAsAtDYKFSssIENsDsPVRSILKSQAWQPL |
| O95425 | S968 | Sugiyama | SVIL | GETESKRALTGRDSGMEKyGsFEEAEASYPILNRAREGDSH |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| O96013 | S41 | Sugiyama | PAK4 KIAA1142 | VHTGFDQHEQKFTGLPRQWQsLIEESARRPKPLVDPACITS |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00533 | S1070 | SIGNOR|iPTMNet | EGFR ERBB ERBB1 HER1 | IDRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDDtFLPVP |
| P00533 | S1071 | SIGNOR|iPTMNet | EGFR ERBB ERBB1 HER1 | DRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDDtFLPVPE |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S15 | Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05423 | S250 | Sugiyama | POLR3D BN51 BN51T | AKMKAPPKAARKTPGLPKDVsVAELLRELSLTKEEELLFLQ |
| P05783 | S305 | Sugiyama | KRT18 CYK18 PIG46 | QSAEVGAAETTLTELRRtVQsLEIDLDsMRNLKAsLENsLR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07101 | S19 | SIGNOR|iPTMNet | TH TYH | __MPTPDATTPQAKGFRRAVsELDAKQAEAIMVRGQGAPGP |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S468 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQ |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T90 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtI |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08621 | S410 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | DEARGGGGGQDNGLEGLGNDsRDMYMESEGGDGYLAPENGY |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09234 | S48 | Sugiyama | SNRPC | RKHKENVKDYYQKWMEEQAQsLIDKTTAAFQQGKIPPTPFS |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0CG41 | S138 | Sugiyama | CTAGE8 | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11717 | S1378 | Sugiyama | IGF2R MPRI | QYACPPFDLTECSFKDGAGNsFDLsSLSRYSDNWEAITGTG |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12956 | S477 | Sugiyama | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P13073 | S74 | Sugiyama | COX4I1 COX4 | HLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAEMN |
| P13073 | S89 | Sugiyama | COX4I1 COX4 | SWssLsMDEKVELYRIKFKEsFAEMNRGSNEWKTVVGGAMF |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S168 | Sugiyama | PRKCSH G19P1 | WKKAREEKQKKLIELQAGKKsLEDQVEMLRTVKEEAEKPER |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | S44 | Sugiyama | NME1 NDPKA NM23 | IIKRFEQKGFRLVGLKFMQAsEDLLKEHyVDLKDRPFFAGL |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16949 | S16 | GPS6 | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P17096 | S102 | Sugiyama | HMGA1 HMGIY | KPRGRPKKLEKEEEEGIsQEssEEEQ_______________ |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17600 | S568 | SIGNOR|iPTMNet | SYN1 | PPAsPsPQRQAGPPQATRQTsVSGPAPPKASGAPPGGQQRQ |
| P17600 | S605 | SIGNOR|iPTMNet | SYN1 | QQRQGPPQKPPGPAGPTRQAsQAGPVPRTGPPTTQQPRPSG |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18615 | S51 | Sugiyama | NELFE RD RDBP | ALKKQSSSSTTSQGGVKRsLsEQPVMDTATATEQAKQLVKS |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18846 | S63 | SIGNOR|iPTMNet | ATF1 | DsSDsIGssQKAHGILARRPsYRKILKDLsSEDTRGRKGDG |
| P18859 | S57 | Sugiyama | ATP5PF ATP5A ATP5J ATPM | DPIQKLFVDKIREYKSKRQTsGGPVDAssEyQQELERELFK |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20290 | S173 | Sugiyama | BTF3 NACB OK/SW-cl.8 | QLGADsLtsLRRLAEALPKQsVDGKAPLAtGEDDDDEVPDL |
| P21333 | S2523 | SIGNOR | FLNA FLN FLN1 | GPYHIGGsPFKAKVTGPRLVsNHsLHEtsSVFVDsLtKATC |
| P21817 | S2843 | SIGNOR|iPTMNet | RYR1 RYDR | IEKAREGEEEKTEKKKTRKIsQsAQtyDPREGYNPQPPDLS |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23528 | S41 | Sugiyama | CFL1 CFL | RKsstPEEVKKRKKAVLFCLsEDKKNIILEEGKEILVGDVG |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S131 | Sugiyama | EIF4B | SIKEFFRGLNIsAVRLPREPsNPERLKGFGyAEFEDLDSLL |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25054 | S2129 | Sugiyama | APC DP2.5 | NSIVSSLHQAAAAACLsRQAssDSDSILSLKsGIsLGsPFH |
| P25705 | S65 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | KtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARVH |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26358 | S91 | Sugiyama | DNMT1 AIM CXXC9 DNMT | EELSEEGYLAKVKSLLNKDLsLENGAHAYNREVNGRLENGN |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27987 | S174 | PSP | ITPKB | IQAQssAIQAPRsPRLGRARsPsPCPFRSSSQPPGRVLVQG |
| P28329 | T574 | SIGNOR | CHAT | YESAsIRRFQEGRVDNIRSAtPEALAFVRAVTDHKAAVPAs |
| P28340 | S1064 | Sugiyama | POLD1 POLD | LNALEERFSRLWTQCQRCQGsLHEDVICTSRDCPIFyMRKK |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P30040 | T62 | Sugiyama | ERP29 C12orf8 ERP28 | DtVtFyKVIPKSKFVLVKFDtQyPyGEKQDEFKRLAENSAS |
| P30043 | T190 | Sugiyama | BLVRB FLR SCAN | RGPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ____ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | S247 | Sugiyama | LRPAP1 A2MRAP | KLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSA |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P30626 | S111 | Sugiyama | SRI | GFNEFKELWAVLNGWRQHFIsFDTDRSGTVDPQELQKALtt |
| P31943 | S23 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | LGTEGGEGFVVKVRGLPWsCsADEVQRFFSDCKIQNGAQGI |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32119 | S151 | Sugiyama | PRDX2 NKEFB TDPX1 | IIDGKGVLRQItVNDLPVGRsVDEALRLVQAFQYTDEHGEV |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P34932 | S363 | Sugiyama | HSPA4 APG2 HSPH2 | GATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAIL |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35270 | S213 | SIGNOR|iPTMNet | SPR | VLNYAPGPLDTDMQQLARETsVDPDMRKGLQELKAKGKLVD |
| P35579 | S1943 | Sugiyama | MYH9 | RGDLPFVVPRRMARKGAGDGsDEEVDGKADGAEAKPAE___ |
| P35637 | S340 | Sugiyama | FUS TLS | PMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFs |
| P35637 | T338 | Sugiyama | FUS TLS | GQPMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKE |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S304 | Sugiyama | RPL3 OK/SW-cl.32 | IYKIGQGyLIKDGKLIKNNAstDyDLSDKSINPLGGFVHYG |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P39687 | S117 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | GNKIKDLstIEPLKKLENLKsLDLFNCEVtNLNDyRENVFK |
| P39687 | T143 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | CEVtNLNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGY |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | T464 | Sugiyama | EIF2S3 EIF2G | SRRVEKHWRLIGWGQIRRGVtIKPtVDDD____________ |
| P41091 | T468 | Sugiyama | EIF2S3 EIF2G | EKHWRLIGWGQIRRGVtIKPtVDDD________________ |
| P41236 | S121 | Sugiyama | PPP1R2 IPP2 | ARKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFE |
| P42224 | S727 | SIGNOR | STAT1 | IsVsEVHPSRLQttDNLLPMsPEEFDEVSRIVGsVEFDSMM |
| P42261 | S645 | SIGNOR|iPTMNet | GRIA1 GLUA1 GLUH1 GLUR1 | IIISSYTANLAAFLTVERMVsPIESAEDLAKQTEIAYGTLE |
| P42261 | S849 | SIGNOR|iPTMNet | GRIA1 GLUA1 GLUH1 GLUR1 | CYKsRsEsKRMKGFCLIPQQsINEAIRTStLPRNsGAGASS |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43034 | S157 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | yEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADMTIKLW |
| P43034 | S399 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | HEHFVTSLDFHKTAPYVVTGsVDQTVKVWECR_________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S1098 | Sugiyama | MKI67 | PAARVTGMKKWPRtPKEEAQsLEDLAGFKELFQtPGPsEEs |
| P46013 | T1764 | Sugiyama | MKI67 | LVDtPtssKPQPKRSLRKADtEEEFLAFRKQTPSAGKAMHt |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P46937 | T114 | Sugiyama | YAP1 YAP65 | sFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQL |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P48058 | S862 | SIGNOR|iPTMNet | GRIA4 GluA4 GLUR4 | AEAKRMKLtFSEAIRNKARLsITGSVGENGRVLTPDCPKAV |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49736 | S139 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | QRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERAtE |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P52272 | S618 | Sugiyama | HNRNPM HNRPM NAGR1 | PALGAGIERMGLAMGGGGGAsFDRAIEMERGNFGGsFAGsF |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S187 | Sugiyama | HNRNPF HNRPF | KALGKHKERIGHRYIEVFKssQEEVRsysDPPLKFMsVQRP |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P55042 | S273 | SIGNOR|iPTMNet | RRAD RAD | LRRDsKEANARRQAGTRRREsLGKKAKRFLGRIVARNsRKM |
| P55055 | S426 | PSP | NR1H2 LXRB NER UNR | TRIKRPQDQLRFPRMLMKLVsLRTLsSVHSEQVFALRLQDK |
| P55081 | S132 | Sugiyama | MFAP1 | VVGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMM |
| P55081 | S133 | Sugiyama | MFAP1 | VGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMMR |
| P55196 | S424 | Sugiyama | AFDN AF6 MLLT4 | HTYEDGSDSRDKPKLYRLQLsVtEVGTEKLDDNSIQLFGPG |
| P60174 | S198 | Sugiyama | TPI1 TPI | TPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtC |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S97 | Sugiyama | TPI1 TPI | GEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELIGQKVAHA |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62072 | S48 | Sugiyama | TIMM10 TIM10 | ACHRKCVPPHYKEAELSKGEsVCLDRCVSKYLDIHERMGKK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | T229 | Sugiyama | YWHAE | LsEEsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQD |
| P62258 | T232 | Sugiyama | YWHAE | EsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQDVED |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | S23 | Sugiyama | RPS28 | TSRVQPIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRsII |
| P62857 | T28 | Sugiyama | RPS28 | PIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRsIIRNVKG |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | S68 | Sugiyama | FKBP1A FKBP1 FKBP12 | KFMLGKQEVIRGWEEGVAQMsVGQRAKLTISPDYAYGATGH |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T80 | Sugiyama | YBX1 NSEP1 YB1 | LGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIKKNNPRKyL |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P98082 | S723 | EPSD|PSP|Sugiyama | DAB2 DOC2 | DANQLLNKINEPPKPAPRQVsLPVTKstDNAFENPFFKDsF |
| Q00688 | S34 | Sugiyama | FKBP3 FKBP25 | QLRSEQLPKKDIIKFLQEHGsDsFLAEHKLLGNIKNVAKTA |
| Q00688 | S36 | Sugiyama | FKBP3 FKBP25 | RSEQLPKKDIIKFLQEHGsDsFLAEHKLLGNIKNVAKTANK |
| Q00688 | T11 | Sugiyama | FKBP3 FKBP25 | __________MAAAVPQRAWtVEQLRSEQLPKKDIIKFLQE |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01970 | S537 | SIGNOR|iPTMNet | PLCB3 | PGLSNGEEVGLEKPSLEPQKsLGDEGLNRGPyVLGPADRED |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06210 | T262 | Sugiyama | GFPT1 GFAT GFPT | sQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDAS |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1051 | Sugiyama | TJP1 ZO1 | PDKEPNLTyEPQLPYVEKQAsRDLEQPtyRyEsssytDQFs |
| Q08945 | S657 | Sugiyama | SSRP1 FACT80 | MEKKSTPSRGsSSKSsSRQLsEsFKSKEFVssDEsssGENK |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q12830 | S1310 | Sugiyama | BPTF FAC1 FALZ | DRVLDDVsIRsPEtKCPKQNsIENDIEEKVSDLASRGQEPS |
| Q13206 | S831 | Sugiyama | DDX10 | DMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWDTL |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13439 | S41 | Sugiyama | GOLGA4 | APAQAssNsstPtRMRsRtssFtEQLDEGtPNRESGDTQSF |
| Q13442 | S176 | Sugiyama | PDAP1 HASPP28 | KKEEERKAKDDATLsGKRMQsLsLNK_______________ |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | S60 | Sugiyama | PDAP1 HASPP28 | QKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGL |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13554 | S26 | Sugiyama | CAMK2B CAM2 CAMK2 CAMKB | TCTRFTDEYQLYEDIGKGAFsVVRRCVKLCTGHEYAAKIIN |
| Q13554 | S280 | Sugiyama | CAMK2B CAM2 CAMK2 CAMKB | RITAHEALKHPWVCQRstVAsMMHRQEtVECLKKFNARRKL |
| Q13554 | T277 | Sugiyama | CAMK2B CAM2 CAMK2 CAMKB | PAKRITAHEALKHPWVCQRstVAsMMHRQEtVECLKKFNAR |
| Q13555 | S26 | Sugiyama | CAMK2G CAMK CAMK-II CAMKG | TCTRFTDDYQLFEELGKGAFsVVRRCVKKTstQEYAAKIIN |
| Q13555 | S280 | EPSD|PSP|Sugiyama | CAMK2G CAMK CAMK-II CAMKG | RITADQALKHPWVCQRstVAsMMHRQEtVECLRKFNARRKL |
| Q13555 | S311 | Sugiyama | CAMK2G CAMK CAMK-II CAMKG | LRKFNARRKLKGAILttMLVsRNFsAAKsLLNKKSDGGVKK |
| Q13555 | S319 | EPSD|PSP | CAMK2G CAMK CAMK-II CAMKG | KLKGAILttMLVsRNFsAAKsLLNKKSDGGVKKRKsSSSVH |
| Q13555 | T277 | Sugiyama | CAMK2G CAMK CAMK-II CAMKG | PAKRITADQALKHPWVCQRstVAsMMHRQEtVECLRKFNAR |
| Q13555 | T287 | GPS6|EPSD | CAMK2G CAMK CAMK-II CAMKG | LKHPWVCQRstVAsMMHRQEtVECLRKFNARRKLKGAILtt |
| Q13555 | T306 | Sugiyama | CAMK2G CAMK CAMK-II CAMKG | EtVECLRKFNARRKLKGAILttMLVsRNFsAAKsLLNKKSD |
| Q13555 | T307 | Sugiyama | CAMK2G CAMK CAMK-II CAMKG | tVECLRKFNARRKLKGAILttMLVsRNFsAAKsLLNKKSDG |
| Q13557 | S26 | Sugiyama | CAMK2D CAMKD | TCTRFTDEyQLFEELGKGAFsVVRRCMKIPTGQEYAAKIIN |
| Q13557 | S280 | Sugiyama | CAMK2D CAMKD | RItAsEALKHPWICQRstVAsMMHRQEtVDCLKKFNARRKL |
| Q13557 | T277 | Sugiyama | CAMK2D CAMKD | PAKRItAsEALKHPWICQRstVAsMMHRQEtVDCLKKFNAR |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q14151 | S613 | Sugiyama | SAFB2 KIAA0138 | ERSSKSQDRKSESKEKRDILsFDKIKEQRERERQRQREREI |
| Q14157 | T241 | Sugiyama | UBAP2L KIAA0144 NICE4 | TWNNTGHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIFtA |
| Q14192 | S238 | Sugiyama | FHL2 DRAL SLIM3 | AKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKCsLsL |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14524 | S516 | SIGNOR | SCN5A | KsDsEDGPRAMNHLsLTRGLsRTSMKPRssRGsIFTFRRRD |
| Q14524 | S571 | SIGNOR | SCN5A | AGESESHHTSLLVPWPLRRtsAQGQPsPGTSAPGHALHGKK |
| Q14524 | T594 | SIGNOR | SCN5A | GQPsPGTSAPGHALHGKKNStVDCNGVVSLLGAGDPEATSP |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14676 | T447 | Sugiyama | MDC1 KIAA0170 NFBD1 | WNRDAEEDMPQRVVLLQRsQtttERDsDtDVEEEELPVENR |
| Q14676 | T449 | Sugiyama | MDC1 KIAA0170 NFBD1 | RDAEEDMPQRVVLLQRsQtttERDsDtDVEEEELPVENREA |
| Q14677 | S163 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | DRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14966 | S1228 | Sugiyama | ZNF638 NP220 ZFML | DLEKKGAEIINPKTALLPSDsVFAEERNLKGILEEsPsEAE |
| Q14978 | S686 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KGKSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_______ |
| Q14978 | S688 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_________ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15003 | S78 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | NDDEKERLQRRRsRVFDLQFstDsPRLLAsPsSRsIDIsAT |
| Q15036 | S437 | Sugiyama | SNX17 KIAA0064 | PLLEsPDAtREsMVKLSsKLsAVsLRGIGsPSTDASAsDVH |
| Q15036 | S440 | Sugiyama | SNX17 KIAA0064 | EsPDAtREsMVKLSsKLsAVsLRGIGsPSTDASAsDVHGNF |
| Q15121 | S116 | SIGNOR|iPTMNet | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15398 | T54 | Sugiyama | DLGAP5 DLG7 KIAA0008 | NRHKEYERNRHFGLKDVNIPtLEGRILVELDETsQGLVPEK |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q15527 | S183 | Sugiyama | SURF2 | sDDsMtDLYPPELFTRKDLGstEDGDGtDDFLtDKEDEKAK |
| Q15527 | T184 | Sugiyama | SURF2 | DDsMtDLYPPELFTRKDLGstEDGDGtDDFLtDKEDEKAKP |
| Q15746 | S1760 | SIGNOR | MYLK MLCK MLCK1 MYLK1 | MARRKWQKTGNAVRAIGRLssMAMISGLSGRKsstGsPtsP |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16204 | S325 | Sugiyama | CCDC6 D10S170 TST1 | QRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGL |
| Q16204 | S327 | Sugiyama | CCDC6 D10S170 TST1 | KLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGLRP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16625 | S471 | EPSD|PSP | OCLN | DEINKELSRLDKELDDYREEsEEyMAAADEYNRLKQVKGsA |
| Q16626 | S163 | Sugiyama | MEA1 MEA | RTMAGVSLPAPGVPAWAREIsDAQWEDVVQKALQARQAsPA |
| Q27J81 | S1192 | Sugiyama | INF2 C14orf151 C14orf173 | EDEDEEDtAPEsALDtsLDKsFsEDAVtDssGsGtLPRARG |
| Q2VIR3 | T464 | Sugiyama | EIF2S3B | SRRVEKHWRLIGWGQIRRGVtIKPtVDDD____________ |
| Q2VIR3 | T468 | Sugiyama | EIF2S3B | EKHWRLIGWGQIRRGVtIKPtVDDD________________ |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T30 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | LDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTI |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5SW79 | S881 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | sstPssLALtsAsRIRERsEsLDPDssMDTtLILKDTEAVM |
| Q5T035 | T62 | Sugiyama | FAM120A2P C9orf129 | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q5TCZ1 | S1038 | Sugiyama | SH3PXD2A FISH KIAA0418 SH3MD1 TKS5 | FSTARSAAAEAKGRLAERAAsQGsDsPLLPAQRNsIPVsPV |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q69YH5 | S210 | Sugiyama | CDCA2 | QSGFPAVLssKRRRIsYQRDsDENLTDAEGKVIGLQIFNID |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UX04 | S203 | Sugiyama | CWC27 SDCCAG10 UNQ438/PRO871 | KKEKPEEEVKKLKPKGTKNFsLLsFGEEAEEEEEEVNRVSQ |
| Q6UX04 | S206 | Sugiyama | CWC27 SDCCAG10 UNQ438/PRO871 | KPEEEVKKLKPKGTKNFsLLsFGEEAEEEEEEVNRVSQSMK |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7L2E3 | S226 | Sugiyama | DHX30 DDX30 KIAA0890 | DFLSMTQQDSHAPLRDSRGssFEMTDDDSAIRALTQFPLPK |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z4V5 | S370 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGRG |
| Q7Z4V5 | S395 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | REDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKK |
| Q7Z4V5 | S399 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKPQSS |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q7Z7L8 | S425 | Sugiyama | C11orf96 AG2 | RstQsLSLQREQLSSCKLRNsLDssDsDsAL__________ |
| Q86UF2 | S138 | Sugiyama | CTAGE6 CTAGE6P | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86W56 | S286 | Sugiyama | PARG | VGSEDVGTGPKNDNKLTRQEsCLGNsPPFEKESEPEsPMDV |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S138 | Sugiyama | CTAGE4 | EKAAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKS |
| Q8N3V7 | S263 | Sugiyama | SYNPO KIAA1029 | HsMEGYSEEASLLRHLEKVAsEEEEVPLVVYLKENAALLTA |
| Q8N6H7 | S368 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | VGTFASGPPKYKDNPFsLGEsFGsRWDTDAAWGMDRVEEKE |
| Q8N6H7 | S432 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | RssGLEssEARQKFAGAKAIssDMFFGREVDAEyEARSRLQ |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8ND56 | S368 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EGNADEEDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEE |
| Q8ND56 | S374 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEERRLNAE |
| Q8NE71 | S109 | Sugiyama | ABCF1 ABC50 | DDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKGG |
| Q8NE71 | S140 | Sugiyama | ABCF1 ABC50 | PRGGKKTKGGNVFAALIQDQsEEEEEEEKHPPKPAKPEKNR |
| Q8NE71 | S166 | Sugiyama | ABCF1 ABC50 | EEKHPPKPAKPEKNRINKAVsEEQQPALKGKKGKEEKSKGK |
| Q8NE71 | T108 | Sugiyama | ABCF1 ABC50 | VDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKG |
| Q8NEF9 | S274 | Sugiyama | SRFBP1 | CEEEKEYFDDstEERFYKQSsMSEDsDsGDDFFIGKVRRTR |
| Q8NEY1 | S377 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | TMPMRsPSKLSHISRLELVEsLDSDEVDLKsGyMsDSDLMG |
| Q8NEY1 | S808 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | TAKSFVKPPsLANLDKVNsNsLDLPSSSDTTHASKVPDLHA |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TEQ6 | S757 | Sugiyama | GEMIN5 | PKAKPKKKKKPTLRtPVKLEsIDGNEEEsMKENsGPVENGV |
| Q8TEU7 | S1117 | Sugiyama | RAPGEF6 PDZGEF2 | NAKKLYEDAQMARKVKQYLssLDVETDEEKFQMMSLQWEPA |
| Q8WVC0 | T477 | Sugiyama | LEO1 RDL | FDVYKAPLQGDHNHLFIRQGtGLQGQAVFKTKLTFRPHstD |
| Q8WWI1 | S1510 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q8WWI1 | S805 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | LQDRESQNQKSTVPSRRRMysFDDVLEEGKRPPtMtVSEAS |
| Q8WWI1 | T932 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VtPRPFGsQtRGISsLPRsYtMDDAWKYNGDVEDIKRtPNN |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q8WXH0 | S2781 | Sugiyama | SYNE2 KIAA1011 NUA | ILSQIRKCKVTHDGILARQQsVEsLAEEVKDKVPSLTTYEG |
| Q92625 | S663 | Sugiyama | ANKS1A ANKS1 KIAA0229 ODIN | sRsEsLsNCsIGKKRLEKsPsFAsEWDEIEKIMssIGEGID |
| Q92688 | S117 | Sugiyama | ANP32B APRIL PHAPI2 | GNKLKDIstLEPLKKLECLKsLDLFNCEVtNLNDyREsVFK |
| Q92733 | T261 | Sugiyama | PRCC TPRC | sPsAIKAAAKSAALQVTKQItQEEDDsDEEVAPENFFsLPE |
| Q92804 | S289 | Sugiyama | TAF15 RBP56 TAF2N | PMINLYTDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFH |
| Q96CT7 | S141 | Sugiyama | CCDC124 | KsHLEVPLEENVNRRVLEEGsVEARTIEDAIAVLsVAEEAA |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q96MH2 | S194 | Sugiyama | HEXIM2 L3 | EAGDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELV |
| Q96MH2 | S51 | Sugiyama | HEXIM2 L3 | QtPPERHDsGGsLPLtPRMEsHsEDEDLAGAVGGLGWNsRs |
| Q96MH2 | T196 | Sugiyama | HEXIM2 L3 | GDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELVRD |
| Q96SB4 | S51 | Sugiyama | SRPK1 | RGsAPHSESDLPEQEEEILGsDDDEQEDPNDYCKGGYHLVK |
| Q96ST3 | S158 | Sugiyama | SIN3A | GSQPQVYNDFLDIMKEFKSQsIDtPGVISRVSQLFKGHPDL |
| Q96T58 | S1268 | Sugiyama | SPEN KIAA0929 MINT SHARP | SRQISEDsERtGGsPsVRHGsFHEDEDPIGsPRLLSVKGsP |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q99755 | S486 | Sugiyama | PIP5K1A | GssFSRRAGssGNsCItyQPsVsGEHKAQVTTKAEVEPGVH |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BTE6 | S174 | Sugiyama | AARSD1 | IEQSVNEKIRDRLPVNVRELsLDDPEVEQVsGRGLPDDHAG |
| Q9BVJ6 | S437 | Sugiyama | UTP14A SDCCAG16 | EEILLREFEERRSLRKRsELsQDAEPAGsQEtKDsGsQEVL |
| Q9BVJ6 | S77 | Sugiyama | UTP14A SDCCAG16 | NRRKLAERSEASLKVSEFNVssEGsGEKLVLADLLEPVKTS |
| Q9BXS6 | S198 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | TAITtPNFKKLHEAHFKEMEsIDQYIERKKKHFEEHNSMNE |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYB0 | S782 | GPS6 | SHANK3 KIAA1650 PROSAP2 PSAP2 | GLPGPEKLPGSLRKGIPRtKsVGEDEKLASLLEGRFPRSTs |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZI7 | T153 | Sugiyama | UPF3B RENT3B UPF3X | FAPFQKAAKKKTKKRDTKVGtIDDDPEyRKFLEsyAtDNEK |
| Q9C0C2 | S1616 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LSEAADsDAHLFQDSTEPRAsRVPssDEEVVEEPQsRRTRM |
| Q9C0C2 | S1620 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ADsDAHLFQDSTEPRAsRVPssDEEVVEEPQsRRTRMsLGT |
| Q9C0C2 | S221 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TyGtTTAPRDEDGstLFRGWsQEGPVKsPAECREEHsKtPE |
| Q9C0C2 | S437 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | HLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQGsQ |
| Q9C0C2 | S899 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | RDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRDHHGRys |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9H1E3 | S113 | Sugiyama | NUCKS1 NUCKS JC7 | RQAASKAASKQREMLMEDVGsEEEQEEEDEAPFQEKDsGsD |
| Q9H1K0 | S548 | Sugiyama | RBSN ZFYVE20 | RELEREREQFRVASLHTRTRsLDFREIGPFQLEPSREPRTH |
| Q9H6S3 | S693 | Sugiyama | EPS8L2 EPS8R2 PP13181 | EGVRVySQLTMQKAFLEKQQsGSELEELMNKFHSMNQRRGE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7E9 | T216 | Sugiyama | C8orf33 | ATRKKSQRVCRPRSIWRAKAtLDMPDEEFRFNFF_______ |
| Q9H814 | S226 | Sugiyama | PHAX RNUXA | RLGNRPEMNYKGRYEITAEDsQEKVADEISFRLQEPKKDLI |
| Q9H814 | S298 | Sugiyama | PHAX RNUXA | NGSRRRTPGGVFLNLLKNtPsISEEQIKDIFyIENQKEYEN |
| Q9NP61 | S367 | Sugiyama | ARFGAP3 ARFGAP1 | DsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDT |
| Q9NP61 | S455 | Sugiyama | ARFGAP3 ARFGAP1 | RQsQADYETRARLERLsAsssIssADLFEEPRKQPAGNysL |
| Q9NRA8 | S977 | Sugiyama | EIF4ENIF1 | KWFGSDVLQQPLPSMPAKVIsVDELEYRQ____________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NYF8 | S198 | Sugiyama | BCLAF1 BTF KIAA0164 | PLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGLsA |
| Q9NZB2 | T413 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q9P013 | T46 | Sugiyama | CWC15 C11orf5 AD-002 HSPC148 | LSKQYSSRDLPSHTKIKYRQttQDAPEEVRNRDFRRELEER |
| Q9P031 | T86 | Sugiyama | CCDC59 BR22 TAP26 HSPC128 | SYKKLLRKEKKAQTSLESQFtDRYPDNLKHLyLAEEERHRK |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UGY1 | S21 | Sugiyama | NOL12 | MGRNKKKKRDGDDRRPRLVLsFDEEKRREyLTGFHKRKVER |
| Q9UHA3 | S68 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | KVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRELWNK |
| Q9UHA3 | T64 | Sugiyama | RSL24D1 C15orf15 RPL24L My024 | RNPRKVRWTKAFRKAAGKELtVDNsFEFEKRRNEPIKYQRE |
| Q9UHB6 | S617 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | FQstsVKsPKtVsPPIRKGWsMsEQSEESVGGRVAERKQVE |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UJU6 | S269 | Sugiyama | DBNL CMAP SH3P7 PP5423 | NEQESAVHPREIFKQKERAMsttsIssPQPGKLRsPFLQKQ |
| Q9UKV3 | S661 | Sugiyama | ACIN1 ACINUS KIAA0670 | SRSRSRSASSNSRKsLsPGVsRDsstsytEtKDPssGQEVA |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9ULD2 | T1204 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRLs |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UMX5 | T48 | Sugiyama | NENF CIR2 SPUF | TARAGQTPRPAERGPPVRLFtEEELARYGGEEEDQPIyLAV |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S854 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFE |
| Q9UQD0 | S561 | SIGNOR | SCN8A MED | sIMNQSLLSIPGSPFLSRHNsKSSIFSFRGPGRFRDPGSEN |
| Q9UQD0 | S641 | SIGNOR | SCN8A MED | SQGSRSSRIFPSLRRSVKRNstVDCNGVVSLIGGPGSHIGG |
| Q9UQD0 | T642 | SIGNOR | SCN8A MED | QGSRSSRIFPSLRRSVKRNstVDCNGVVSLIGGPGSHIGGR |
| Q9UQL6 | S259 | SIGNOR | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9UQM7 | S25 | Sugiyama | CAMK2A CAMKA KIAA0968 | TCTRFTEEYQLFEELGKGAFsVVRRCVKVLAGQEYAAKIIN |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2H0 | S977 | Sugiyama | DLGAP4 DAP4 KIAA0964 SAPAP4 | RKRLLAAKRAAsVRQNsAtEsADsIEIYVPEAQTRL_____ |
| Q9Y2H0 | S980 | Sugiyama | DLGAP4 DAP4 KIAA0964 SAPAP4 | LLAAKRAAsVRQNsAtEsADsIEIYVPEAQTRL________ |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2T7 | T115 | Sugiyama | YBX2 CSDA3 MSY2 | LGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIKRNNPRKFL |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2X7 | S592 | Sugiyama | GIT1 | PLLsCsQEGsRHtsKLsRHGsGADsDyENtQSGDPLLGLEG |
| Q9Y3F4 | S153 | Sugiyama | STRAP MAWD UNRIP | EAEPKEISGHTSGIKKALWCsEDKQILsADDKtVRLWDHAT |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y4W2 | S641 | Sugiyama | LAS1L MSTP060 | ENARLLAQKRGALQGsAWQVssEDVRWDTFPLGRMPGQTED |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y608 | S18 | Sugiyama | LRRFIP2 | ___MGTPASGRKRTPVKDRFsAEDEALsNIAREAEARLAAK |
| Q9Y618 | S2407 | SIGNOR | NCOR2 CTG26 | SDHTLTSPGGGGKAKVSGRPsSRKAKsPAPGLASGDRPPsV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 1.999099e-10 | 9.699 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.085976e-09 | 8.964 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.272207e-09 | 8.895 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.524752e-09 | 8.453 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.973370e-09 | 8.303 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.167308e-08 | 7.499 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.669090e-08 | 7.115 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.036079e-07 | 6.985 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.495903e-07 | 6.825 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.156221e-06 | 5.937 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.346201e-06 | 5.630 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.453411e-06 | 5.462 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.773629e-06 | 5.169 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.873107e-06 | 5.052 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.580205e-06 | 5.067 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.289036e-05 | 4.890 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.398107e-05 | 4.854 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.467303e-05 | 4.833 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.761154e-05 | 4.754 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.997408e-05 | 4.700 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.207220e-05 | 4.656 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.207220e-05 | 4.656 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.276461e-05 | 4.643 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.704859e-05 | 4.568 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.923120e-05 | 4.534 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.654346e-05 | 4.437 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.834662e-05 | 4.416 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.337371e-05 | 4.363 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.829335e-05 | 4.316 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.201015e-05 | 4.284 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.201015e-05 | 4.284 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.977222e-05 | 4.303 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.199673e-05 | 4.208 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.578291e-05 | 4.120 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.748579e-05 | 4.111 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.491644e-05 | 4.071 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.407852e-05 | 4.027 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.169525e-04 | 3.932 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.271708e-04 | 3.896 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.339694e-04 | 3.873 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.555436e-04 | 3.808 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.530030e-04 | 3.815 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.640327e-04 | 3.785 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.820666e-04 | 3.740 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.340900e-04 | 3.631 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.268983e-04 | 3.644 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.381793e-04 | 3.623 | 1 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.659597e-04 | 3.575 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.171211e-04 | 3.499 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.309944e-04 | 3.480 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.427218e-04 | 3.465 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.613171e-04 | 3.442 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.599640e-04 | 3.444 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.848262e-04 | 3.415 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.848262e-04 | 3.415 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.935445e-04 | 3.307 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.113912e-04 | 3.214 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.113912e-04 | 3.214 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.212535e-04 | 3.207 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.430901e-04 | 3.192 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.641864e-04 | 3.178 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.207841e-04 | 3.142 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.932403e-04 | 3.101 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.916484e-04 | 3.101 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.134918e-04 | 3.090 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.932403e-04 | 3.101 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.302020e-04 | 3.081 | 1 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.019542e-04 | 3.045 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.794605e-04 | 3.009 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.948017e-04 | 3.002 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.061233e-03 | 2.974 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.121744e-03 | 2.950 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.182111e-03 | 2.927 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.197880e-03 | 2.922 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.270371e-03 | 2.896 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.327451e-03 | 2.877 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.397269e-03 | 2.855 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.339151e-03 | 2.873 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.400350e-03 | 2.854 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.418413e-03 | 2.848 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.418413e-03 | 2.848 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.455562e-03 | 2.837 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.661836e-03 | 2.779 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.661836e-03 | 2.779 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.661836e-03 | 2.779 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.661836e-03 | 2.779 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.590929e-03 | 2.798 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.694561e-03 | 2.771 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.661954e-03 | 2.779 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.769420e-03 | 2.752 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.576733e-03 | 2.802 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.859665e-03 | 2.731 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.993035e-03 | 2.700 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.116370e-03 | 2.674 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.130317e-03 | 2.672 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.180124e-03 | 2.662 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.363873e-03 | 2.626 | 1 | 1 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.288710e-03 | 2.640 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.354143e-03 | 2.628 | 1 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.354143e-03 | 2.628 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.473113e-03 | 2.607 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.529340e-03 | 2.597 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.556057e-03 | 2.592 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.773249e-03 | 2.557 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.792472e-03 | 2.554 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.832775e-03 | 2.548 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.182258e-03 | 2.497 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.167384e-03 | 2.499 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.182258e-03 | 2.497 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.288256e-03 | 2.483 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.424219e-03 | 2.465 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.449555e-03 | 2.462 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.520181e-03 | 2.453 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.605081e-03 | 2.443 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.609750e-03 | 2.443 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.624846e-03 | 2.441 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.648267e-03 | 2.438 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.683868e-03 | 2.434 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.979217e-03 | 2.400 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.999510e-03 | 2.398 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.999510e-03 | 2.398 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.785218e-03 | 2.422 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.476287e-03 | 2.349 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.476287e-03 | 2.349 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.476287e-03 | 2.349 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.476287e-03 | 2.349 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.637729e-03 | 2.334 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.742617e-03 | 2.324 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.891754e-03 | 2.311 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.891754e-03 | 2.311 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.313593e-03 | 2.275 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.399826e-03 | 2.268 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.701668e-03 | 2.244 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.859199e-03 | 2.232 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.649689e-03 | 2.177 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.163185e-03 | 2.145 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.304045e-03 | 2.136 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.371221e-03 | 2.132 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.727637e-03 | 2.112 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.757418e-03 | 2.110 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.836000e-03 | 2.106 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.912850e-03 | 2.102 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.921026e-03 | 2.101 | 1 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.207993e-03 | 2.086 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.503671e-03 | 2.070 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.503671e-03 | 2.070 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.667866e-03 | 2.062 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.735042e-03 | 2.059 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.011481e-03 | 2.045 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.350964e-03 | 2.029 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.139315e-03 | 2.039 | 1 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.842047e-03 | 2.007 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.842047e-03 | 2.007 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.897182e-03 | 2.004 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.015141e-02 | 1.993 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.021223e-02 | 1.991 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.028562e-02 | 1.988 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.043433e-02 | 1.982 | 1 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.043433e-02 | 1.982 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.089455e-02 | 1.963 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.112322e-02 | 1.954 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.135172e-02 | 1.945 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.168285e-02 | 1.932 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.229344e-02 | 1.910 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.231152e-02 | 1.910 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.231354e-02 | 1.910 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.237627e-02 | 1.907 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.237720e-02 | 1.907 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.386207e-02 | 1.858 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.364495e-02 | 1.865 | 1 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.458134e-02 | 1.836 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.386207e-02 | 1.858 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.458134e-02 | 1.836 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.558280e-02 | 1.807 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.568664e-02 | 1.804 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.568664e-02 | 1.804 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.596266e-02 | 1.797 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.640603e-02 | 1.785 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.674120e-02 | 1.776 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.706995e-02 | 1.768 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.757241e-02 | 1.755 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.812097e-02 | 1.742 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.812097e-02 | 1.742 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.812097e-02 | 1.742 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.020160e-02 | 1.695 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.842275e-02 | 1.735 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.842275e-02 | 1.735 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.083672e-02 | 1.681 | 1 | 1 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.925154e-02 | 1.716 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.996136e-02 | 1.700 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.973179e-02 | 1.705 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.065499e-02 | 1.685 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.965180e-02 | 1.707 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.971788e-02 | 1.705 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.879775e-02 | 1.726 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.026256e-02 | 1.693 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.986230e-02 | 1.702 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.083672e-02 | 1.681 | 1 | 1 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.092114e-02 | 1.679 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.092114e-02 | 1.679 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.183957e-02 | 1.661 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.183957e-02 | 1.661 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.332523e-02 | 1.632 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.332523e-02 | 1.632 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.521491e-02 | 1.598 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.521491e-02 | 1.598 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.638780e-02 | 1.579 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.577590e-02 | 1.589 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.577590e-02 | 1.589 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.376661e-02 | 1.624 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.376661e-02 | 1.624 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.383834e-02 | 1.623 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.640346e-02 | 1.578 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.604030e-02 | 1.584 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.604030e-02 | 1.584 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.492086e-02 | 1.603 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.343629e-02 | 1.630 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.643659e-02 | 1.578 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.297813e-02 | 1.639 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.643659e-02 | 1.578 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.727558e-02 | 1.564 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.747091e-02 | 1.561 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.747091e-02 | 1.561 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.812902e-02 | 1.551 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.921266e-02 | 1.534 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.921266e-02 | 1.534 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.013513e-02 | 1.521 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.053741e-02 | 1.515 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.121639e-02 | 1.506 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.134800e-02 | 1.504 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.204911e-02 | 1.494 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.210927e-02 | 1.493 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.220788e-02 | 1.492 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.220788e-02 | 1.492 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.425128e-02 | 1.465 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.445366e-02 | 1.463 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.554751e-02 | 1.449 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.575335e-02 | 1.447 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.577503e-02 | 1.446 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.625530e-02 | 1.441 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.910689e-02 | 1.408 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.910689e-02 | 1.408 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.662423e-02 | 1.436 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.662423e-02 | 1.436 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.662423e-02 | 1.436 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.662423e-02 | 1.436 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.662423e-02 | 1.436 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.998169e-02 | 1.398 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.905567e-02 | 1.408 | 1 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.905567e-02 | 1.408 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.905567e-02 | 1.408 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.905567e-02 | 1.408 | 1 | 1 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.722467e-02 | 1.429 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.964671e-02 | 1.402 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.059447e-02 | 1.392 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.998169e-02 | 1.398 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.998169e-02 | 1.398 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.295653e-02 | 1.367 | 1 | 1 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.295653e-02 | 1.367 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.996892e-02 | 1.398 | 1 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.104250e-02 | 1.387 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.904573e-02 | 1.408 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.385752e-02 | 1.358 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.021987e-02 | 1.396 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 4.385752e-02 | 1.358 | 1 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.662423e-02 | 1.436 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.478544e-02 | 1.349 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.478544e-02 | 1.349 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.478544e-02 | 1.349 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.494746e-02 | 1.347 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.552521e-02 | 1.342 | 1 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.654284e-02 | 1.332 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.665812e-02 | 1.331 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.773037e-02 | 1.321 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.809223e-02 | 1.318 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.809223e-02 | 1.318 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.882356e-02 | 1.311 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.882356e-02 | 1.311 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.882356e-02 | 1.311 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.947086e-02 | 1.306 | 1 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.947086e-02 | 1.306 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.947086e-02 | 1.306 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.010031e-02 | 1.300 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.010031e-02 | 1.300 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.179241e-02 | 1.286 | 1 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.270531e-02 | 1.278 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.270531e-02 | 1.278 | 1 | 1 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.270531e-02 | 1.278 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.308947e-02 | 1.275 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.374949e-02 | 1.270 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.421224e-02 | 1.266 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.472017e-02 | 1.262 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.509000e-02 | 1.259 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.602505e-02 | 1.252 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.602505e-02 | 1.252 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.602505e-02 | 1.252 | 1 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.602505e-02 | 1.252 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.635733e-02 | 1.249 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.635733e-02 | 1.249 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.676501e-02 | 1.246 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.684631e-02 | 1.245 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.684631e-02 | 1.245 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.756723e-02 | 1.240 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.038627e-02 | 1.219 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.076366e-02 | 1.216 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.145081e-02 | 1.211 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.158821e-02 | 1.211 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.772616e-02 | 1.109 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.772616e-02 | 1.109 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.299275e-02 | 1.201 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.299275e-02 | 1.201 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.187549e-02 | 1.143 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.342863e-02 | 1.198 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.142459e-02 | 1.146 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.559910e-02 | 1.121 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.793917e-02 | 1.168 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.696144e-02 | 1.114 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.713023e-02 | 1.113 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.420599e-02 | 1.192 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.142459e-02 | 1.146 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.838591e-02 | 1.165 | 1 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.421144e-02 | 1.192 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.727485e-02 | 1.172 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.808275e-02 | 1.167 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.282315e-02 | 1.202 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.282315e-02 | 1.202 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.801940e-02 | 1.108 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.907998e-02 | 1.102 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.907998e-02 | 1.102 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.907998e-02 | 1.102 | 1 | 1 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.963830e-02 | 1.099 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.963830e-02 | 1.099 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.001826e-02 | 1.097 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.001826e-02 | 1.097 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.131478e-02 | 1.090 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.145026e-02 | 1.089 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.145026e-02 | 1.089 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.231533e-02 | 1.085 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.412819e-02 | 1.075 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.412819e-02 | 1.075 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.420167e-02 | 1.075 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.638834e-02 | 1.064 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.640093e-02 | 1.063 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.695386e-02 | 1.061 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.809250e-02 | 1.055 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 8.809250e-02 | 1.055 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.863182e-02 | 1.052 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.863182e-02 | 1.052 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.863182e-02 | 1.052 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.921146e-02 | 1.050 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.921146e-02 | 1.050 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.921146e-02 | 1.050 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.921146e-02 | 1.050 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.145257e-02 | 1.039 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.222219e-02 | 1.035 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.222219e-02 | 1.035 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.222219e-02 | 1.035 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.222219e-02 | 1.035 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.270204e-02 | 1.033 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.270204e-02 | 1.033 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.343858e-02 | 1.029 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.535575e-02 | 1.021 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.159775e-01 | 0.936 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.159775e-01 | 0.936 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.159775e-01 | 0.936 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.159775e-01 | 0.936 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.159775e-01 | 0.936 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.159775e-01 | 0.936 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.159775e-01 | 0.936 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.159775e-01 | 0.936 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.272924e-01 | 0.895 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.272924e-01 | 0.895 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.272924e-01 | 0.895 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.272924e-01 | 0.895 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.014377e-01 | 0.994 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.276252e-01 | 0.894 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.276252e-01 | 0.894 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.276252e-01 | 0.894 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.166250e-01 | 0.933 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.041201e-01 | 0.982 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.041201e-01 | 0.982 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.041201e-01 | 0.982 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.208465e-01 | 0.918 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.058122e-01 | 0.975 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.058122e-01 | 0.975 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.203761e-01 | 0.919 | 1 | 1 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.047754e-01 | 0.980 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.137972e-01 | 0.944 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.900247e-02 | 1.004 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.259792e-01 | 0.900 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.203538e-01 | 0.920 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.036643e-01 | 0.984 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.251038e-01 | 0.903 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.022834e-01 | 0.990 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.112818e-01 | 0.954 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.041201e-01 | 0.982 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.900247e-02 | 1.004 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.203538e-01 | 0.920 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.022834e-01 | 0.990 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.166250e-01 | 0.933 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.064604e-01 | 0.973 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.261073e-01 | 0.899 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.261073e-01 | 0.899 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.091208e-01 | 0.962 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.208465e-01 | 0.918 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.210914e-01 | 0.917 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.203761e-01 | 0.919 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.268222e-01 | 0.897 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.179546e-01 | 0.928 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.003870e-01 | 0.998 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.272924e-01 | 0.895 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.272924e-01 | 0.895 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.203761e-01 | 0.919 | 1 | 1 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.137972e-01 | 0.944 | 1 | 1 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.093861e-01 | 0.961 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.251343e-01 | 0.903 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.148584e-01 | 0.940 | 1 | 1 |
| Netrin-1 signaling | R-HSA-373752 | 1.146791e-01 | 0.941 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.120428e-01 | 0.951 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.313798e-01 | 0.881 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.318936e-01 | 0.880 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.318936e-01 | 0.880 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.318936e-01 | 0.880 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.347473e-01 | 0.870 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.358730e-01 | 0.867 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.358730e-01 | 0.867 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.360899e-01 | 0.866 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.378228e-01 | 0.861 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.378228e-01 | 0.861 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.393270e-01 | 0.856 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.413730e-01 | 0.850 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.436333e-01 | 0.843 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.439905e-01 | 0.842 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.457121e-01 | 0.837 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.457121e-01 | 0.837 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.457121e-01 | 0.837 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.498873e-01 | 0.824 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.513545e-01 | 0.820 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.513545e-01 | 0.820 | 1 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.521481e-01 | 0.818 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.522538e-01 | 0.817 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.522678e-01 | 0.817 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.524222e-01 | 0.817 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.524222e-01 | 0.817 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.524222e-01 | 0.817 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.559102e-01 | 0.807 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.559102e-01 | 0.807 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.559102e-01 | 0.807 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.559102e-01 | 0.807 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.559102e-01 | 0.807 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.566263e-01 | 0.805 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.577131e-01 | 0.802 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.577131e-01 | 0.802 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.577131e-01 | 0.802 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.577131e-01 | 0.802 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.604309e-01 | 0.795 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.604309e-01 | 0.795 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.604309e-01 | 0.795 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.604309e-01 | 0.795 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.608298e-01 | 0.794 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.620756e-01 | 0.790 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.630651e-01 | 0.788 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.672555e-01 | 0.777 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.674421e-01 | 0.776 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.694625e-01 | 0.771 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.696683e-01 | 0.770 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.696683e-01 | 0.770 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.696683e-01 | 0.770 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.696683e-01 | 0.770 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.696683e-01 | 0.770 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.696683e-01 | 0.770 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.185102e-01 | 0.661 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.185102e-01 | 0.661 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.185102e-01 | 0.661 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.185102e-01 | 0.661 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.185102e-01 | 0.661 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.185102e-01 | 0.661 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.185102e-01 | 0.661 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.185102e-01 | 0.661 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.139570e-01 | 0.670 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.139570e-01 | 0.670 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.859088e-01 | 0.731 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.591455e-01 | 0.586 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.591455e-01 | 0.586 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.591455e-01 | 0.586 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.172453e-01 | 0.663 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.172453e-01 | 0.663 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.842785e-01 | 0.735 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.091880e-01 | 0.679 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.091880e-01 | 0.679 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.349789e-01 | 0.629 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.874372e-01 | 0.727 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.424722e-01 | 0.615 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.424722e-01 | 0.615 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.254141e-01 | 0.647 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.452726e-01 | 0.610 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.452726e-01 | 0.610 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.455801e-01 | 0.610 | 1 | 1 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.974208e-01 | 0.705 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.254944e-01 | 0.647 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.304066e-01 | 0.638 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.766205e-01 | 0.753 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.985278e-01 | 0.702 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.975456e-01 | 0.704 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.172453e-01 | 0.663 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.172453e-01 | 0.663 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.254141e-01 | 0.647 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.950121e-01 | 0.710 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.331097e-01 | 0.632 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.728659e-01 | 0.762 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.728659e-01 | 0.762 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.874372e-01 | 0.727 | 1 | 1 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.444424e-01 | 0.612 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.591455e-01 | 0.586 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.444424e-01 | 0.612 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.139570e-01 | 0.670 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.172453e-01 | 0.663 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.201626e-01 | 0.657 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.435434e-01 | 0.613 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.589161e-01 | 0.587 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.751993e-01 | 0.756 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.874372e-01 | 0.727 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.100407e-01 | 0.678 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.559558e-01 | 0.592 | 1 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.185102e-01 | 0.661 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.859088e-01 | 0.731 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.591455e-01 | 0.586 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.591455e-01 | 0.586 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.495616e-01 | 0.603 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.091880e-01 | 0.679 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.091880e-01 | 0.679 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.349789e-01 | 0.629 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.201626e-01 | 0.657 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.061112e-01 | 0.686 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.950121e-01 | 0.710 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.943962e-01 | 0.711 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.842785e-01 | 0.735 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.100407e-01 | 0.678 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.304066e-01 | 0.638 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.859088e-01 | 0.731 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.859088e-01 | 0.731 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.495616e-01 | 0.603 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.337244e-01 | 0.631 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.591455e-01 | 0.586 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.275717e-01 | 0.643 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.152445e-01 | 0.667 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.209863e-01 | 0.656 | 1 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.979285e-01 | 0.703 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.859088e-01 | 0.731 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.275717e-01 | 0.643 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.424722e-01 | 0.615 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.114966e-01 | 0.675 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.591455e-01 | 0.586 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.270721e-01 | 0.644 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.139570e-01 | 0.670 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.578276e-01 | 0.589 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.018575e-01 | 0.695 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.893106e-01 | 0.723 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.155063e-01 | 0.667 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.614723e-01 | 0.583 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.640112e-01 | 0.578 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.642009e-01 | 0.578 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.647359e-01 | 0.577 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.653467e-01 | 0.576 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.656117e-01 | 0.576 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.678911e-01 | 0.572 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.681576e-01 | 0.572 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.694575e-01 | 0.570 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.694575e-01 | 0.570 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.091561e-01 | 0.510 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.091561e-01 | 0.510 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.091561e-01 | 0.510 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 3.091561e-01 | 0.510 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.091561e-01 | 0.510 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.091561e-01 | 0.510 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.091561e-01 | 0.510 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.091561e-01 | 0.510 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.091561e-01 | 0.510 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.091561e-01 | 0.510 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.091561e-01 | 0.510 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.091561e-01 | 0.510 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.892924e-01 | 0.410 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.892924e-01 | 0.410 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.892924e-01 | 0.410 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.892924e-01 | 0.410 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.892924e-01 | 0.410 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.892924e-01 | 0.410 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.892924e-01 | 0.410 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.892924e-01 | 0.410 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.044298e-01 | 0.517 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.044298e-01 | 0.517 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.044298e-01 | 0.517 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.044298e-01 | 0.517 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.825232e-01 | 0.549 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.825232e-01 | 0.549 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 3.491802e-01 | 0.457 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.491802e-01 | 0.457 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.491802e-01 | 0.457 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.491802e-01 | 0.457 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.601373e-01 | 0.337 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.601373e-01 | 0.337 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.601373e-01 | 0.337 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.601373e-01 | 0.337 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.601373e-01 | 0.337 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.601373e-01 | 0.337 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.601373e-01 | 0.337 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.158236e-01 | 0.501 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.158236e-01 | 0.501 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.158236e-01 | 0.501 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.158236e-01 | 0.501 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.158236e-01 | 0.501 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.158236e-01 | 0.501 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.884933e-01 | 0.540 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.929116e-01 | 0.406 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.929116e-01 | 0.406 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.929116e-01 | 0.406 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.929116e-01 | 0.406 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.158738e-01 | 0.500 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.158738e-01 | 0.500 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.158738e-01 | 0.500 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.863557e-01 | 0.543 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.863557e-01 | 0.543 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.123534e-01 | 0.505 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.434542e-01 | 0.464 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.434542e-01 | 0.464 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.823667e-01 | 0.418 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.352584e-01 | 0.361 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.352584e-01 | 0.361 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.227675e-01 | 0.282 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.227675e-01 | 0.282 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.227675e-01 | 0.282 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.227675e-01 | 0.282 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.227675e-01 | 0.282 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.287550e-01 | 0.483 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.151495e-01 | 0.382 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.151495e-01 | 0.382 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.151495e-01 | 0.382 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.759536e-01 | 0.322 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.759536e-01 | 0.322 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.759536e-01 | 0.322 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.844347e-01 | 0.415 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.473505e-01 | 0.349 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.501688e-01 | 0.456 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.084901e-01 | 0.389 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.935304e-01 | 0.405 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.576146e-01 | 0.447 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.529584e-01 | 0.344 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.788135e-01 | 0.320 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.148106e-01 | 0.288 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.148106e-01 | 0.288 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.148106e-01 | 0.288 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.148106e-01 | 0.288 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.148106e-01 | 0.288 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.148106e-01 | 0.288 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.148106e-01 | 0.288 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.199721e-01 | 0.377 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.366948e-01 | 0.360 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.561221e-01 | 0.341 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.795290e-01 | 0.319 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.580832e-01 | 0.339 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.094091e-01 | 0.293 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.795466e-01 | 0.319 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.055795e-01 | 0.296 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.055795e-01 | 0.296 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.783465e-01 | 0.320 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.783465e-01 | 0.320 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.981357e-01 | 0.303 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.208241e-01 | 0.283 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.696649e-01 | 0.328 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.141345e-01 | 0.289 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.195604e-01 | 0.284 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.317213e-01 | 0.274 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.025044e-01 | 0.395 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.259576e-01 | 0.371 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.886764e-01 | 0.540 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.825232e-01 | 0.549 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.603316e-01 | 0.443 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.561221e-01 | 0.341 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.264332e-01 | 0.370 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.164195e-01 | 0.287 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.316278e-01 | 0.479 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.208241e-01 | 0.283 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.986284e-01 | 0.399 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.436336e-01 | 0.353 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.208241e-01 | 0.283 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.158738e-01 | 0.500 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.603316e-01 | 0.443 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.920319e-01 | 0.535 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.091573e-01 | 0.293 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.091573e-01 | 0.293 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.929116e-01 | 0.406 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.352584e-01 | 0.361 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.352584e-01 | 0.361 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.227675e-01 | 0.282 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.227675e-01 | 0.282 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.788135e-01 | 0.320 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.603316e-01 | 0.443 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.883579e-01 | 0.311 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.947241e-01 | 0.306 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.958735e-01 | 0.402 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.044298e-01 | 0.517 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.986284e-01 | 0.399 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.233013e-01 | 0.490 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.019176e-01 | 0.520 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.408400e-01 | 0.467 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.602068e-01 | 0.337 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.359008e-01 | 0.361 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.825232e-01 | 0.549 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.884933e-01 | 0.540 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.158738e-01 | 0.500 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.352584e-01 | 0.361 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.227675e-01 | 0.282 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.786291e-01 | 0.555 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.759536e-01 | 0.322 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.473505e-01 | 0.349 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.473505e-01 | 0.349 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.788135e-01 | 0.320 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.148106e-01 | 0.288 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.148106e-01 | 0.288 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.795290e-01 | 0.319 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.476100e-01 | 0.459 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.628732e-01 | 0.335 | 1 | 1 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.020719e-01 | 0.396 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.919613e-01 | 0.407 | 1 | 1 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.280779e-01 | 0.277 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.955861e-01 | 0.403 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.788135e-01 | 0.320 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.055795e-01 | 0.296 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.590431e-01 | 0.445 | 1 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.309825e-01 | 0.275 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.628084e-01 | 0.440 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.491802e-01 | 0.457 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.352584e-01 | 0.361 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.148106e-01 | 0.288 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.052162e-01 | 0.392 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.932659e-01 | 0.307 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.280779e-01 | 0.277 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.189019e-01 | 0.285 | 1 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.868200e-01 | 0.412 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.778083e-01 | 0.321 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.151575e-01 | 0.382 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.995967e-01 | 0.398 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.044298e-01 | 0.517 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.044298e-01 | 0.517 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.929116e-01 | 0.406 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.561221e-01 | 0.341 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.633099e-01 | 0.440 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.788135e-01 | 0.320 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.074285e-01 | 0.512 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.114410e-01 | 0.291 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.573934e-01 | 0.447 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.091561e-01 | 0.510 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.892924e-01 | 0.410 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.892924e-01 | 0.410 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.892924e-01 | 0.410 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.892924e-01 | 0.410 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.601373e-01 | 0.337 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.601373e-01 | 0.337 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.158738e-01 | 0.500 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.352584e-01 | 0.361 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.759536e-01 | 0.322 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.759536e-01 | 0.322 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.637087e-01 | 0.439 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.788135e-01 | 0.320 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.148106e-01 | 0.288 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.419479e-01 | 0.355 | 1 | 1 |
| PKA activation | R-HSA-163615 | 5.390322e-01 | 0.268 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.390322e-01 | 0.268 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.488012e-01 | 0.348 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.971613e-01 | 0.527 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.359847e-01 | 0.271 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.153154e-01 | 0.501 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.798944e-01 | 0.420 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.798944e-01 | 0.420 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.132369e-01 | 0.290 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.094091e-01 | 0.293 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.091573e-01 | 0.293 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.352584e-01 | 0.361 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.397205e-01 | 0.357 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.580832e-01 | 0.339 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.741218e-01 | 0.562 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.473505e-01 | 0.349 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.859671e-01 | 0.544 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.825232e-01 | 0.549 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.158236e-01 | 0.501 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.929116e-01 | 0.406 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.094091e-01 | 0.293 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.637087e-01 | 0.439 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.841696e-01 | 0.415 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.823667e-01 | 0.418 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.354577e-01 | 0.474 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.749707e-01 | 0.323 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.072167e-01 | 0.390 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.921261e-01 | 0.534 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.749707e-01 | 0.323 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.749707e-01 | 0.323 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.123534e-01 | 0.505 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.123534e-01 | 0.505 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.753523e-01 | 0.426 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.260269e-01 | 0.279 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.850561e-01 | 0.545 | 1 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.390322e-01 | 0.268 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.452270e-01 | 0.462 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.139887e-01 | 0.503 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.091561e-01 | 0.510 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.044298e-01 | 0.517 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.601373e-01 | 0.337 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.123534e-01 | 0.505 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.352584e-01 | 0.361 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.844347e-01 | 0.415 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.844347e-01 | 0.415 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.148106e-01 | 0.288 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.878389e-01 | 0.411 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.151495e-01 | 0.382 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.803336e-01 | 0.420 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.877816e-01 | 0.411 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.491866e-01 | 0.457 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.844347e-01 | 0.415 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.502616e-01 | 0.456 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.013389e-01 | 0.396 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.961843e-01 | 0.528 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.317213e-01 | 0.274 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.236686e-01 | 0.490 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.892924e-01 | 0.410 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.892924e-01 | 0.410 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.491802e-01 | 0.457 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.601373e-01 | 0.337 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.929116e-01 | 0.406 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.352584e-01 | 0.361 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.227675e-01 | 0.282 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.759536e-01 | 0.322 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.919613e-01 | 0.407 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.390322e-01 | 0.268 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.798944e-01 | 0.420 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.158738e-01 | 0.500 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.434542e-01 | 0.464 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 3.823667e-01 | 0.418 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.252817e-01 | 0.280 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.958735e-01 | 0.402 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.529584e-01 | 0.344 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.359847e-01 | 0.271 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.892924e-01 | 0.410 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.491802e-01 | 0.457 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.601373e-01 | 0.337 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.929116e-01 | 0.406 | 1 | 1 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.352584e-01 | 0.361 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.352584e-01 | 0.361 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.148106e-01 | 0.288 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.792677e-01 | 0.319 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.935304e-01 | 0.405 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.158738e-01 | 0.500 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.844347e-01 | 0.415 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.251330e-01 | 0.371 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.491866e-01 | 0.457 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.561221e-01 | 0.341 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.390322e-01 | 0.268 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.094091e-01 | 0.293 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.823667e-01 | 0.418 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.759536e-01 | 0.322 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.390322e-01 | 0.268 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.404766e-01 | 0.267 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.411063e-01 | 0.267 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.444664e-01 | 0.264 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.490656e-01 | 0.260 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.517082e-01 | 0.258 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.517082e-01 | 0.258 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.517082e-01 | 0.258 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.517082e-01 | 0.258 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.517082e-01 | 0.258 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.517082e-01 | 0.258 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.517082e-01 | 0.258 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.517082e-01 | 0.258 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.544750e-01 | 0.256 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.544750e-01 | 0.256 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.558197e-01 | 0.255 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.558197e-01 | 0.255 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.610051e-01 | 0.251 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.610051e-01 | 0.251 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.610051e-01 | 0.251 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.676003e-01 | 0.246 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.676003e-01 | 0.246 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.676003e-01 | 0.246 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.676003e-01 | 0.246 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.676003e-01 | 0.246 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.676003e-01 | 0.246 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.676003e-01 | 0.246 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.676003e-01 | 0.246 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.691682e-01 | 0.245 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.691682e-01 | 0.245 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.726354e-01 | 0.242 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.761134e-01 | 0.239 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.781352e-01 | 0.238 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.781352e-01 | 0.238 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.781352e-01 | 0.238 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.781352e-01 | 0.238 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.781352e-01 | 0.238 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.781352e-01 | 0.238 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.781352e-01 | 0.238 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.781352e-01 | 0.238 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.781352e-01 | 0.238 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 5.781352e-01 | 0.238 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.781352e-01 | 0.238 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.781352e-01 | 0.238 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.781352e-01 | 0.238 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.798871e-01 | 0.237 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.798871e-01 | 0.237 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.804861e-01 | 0.236 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.844798e-01 | 0.233 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.860017e-01 | 0.232 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.865782e-01 | 0.232 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.865782e-01 | 0.232 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.865782e-01 | 0.232 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.865782e-01 | 0.232 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.865782e-01 | 0.232 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.865782e-01 | 0.232 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.865782e-01 | 0.232 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.865782e-01 | 0.232 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.865782e-01 | 0.232 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.865782e-01 | 0.232 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.865782e-01 | 0.232 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.865782e-01 | 0.232 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.865782e-01 | 0.232 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.865782e-01 | 0.232 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.865782e-01 | 0.232 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.926752e-01 | 0.227 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.946780e-01 | 0.226 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.950511e-01 | 0.225 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.950511e-01 | 0.225 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.950511e-01 | 0.225 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.950511e-01 | 0.225 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.974524e-01 | 0.224 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.995191e-01 | 0.222 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.995191e-01 | 0.222 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.995191e-01 | 0.222 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.025136e-01 | 0.220 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.027237e-01 | 0.220 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.031885e-01 | 0.220 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.031885e-01 | 0.220 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.031885e-01 | 0.220 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.050800e-01 | 0.218 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.078633e-01 | 0.216 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.085897e-01 | 0.216 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.102570e-01 | 0.214 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.108599e-01 | 0.214 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.122623e-01 | 0.213 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.144948e-01 | 0.211 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.173116e-01 | 0.209 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.180777e-01 | 0.209 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.190577e-01 | 0.208 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.193943e-01 | 0.208 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.193943e-01 | 0.208 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.193943e-01 | 0.208 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.213401e-01 | 0.207 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.213401e-01 | 0.207 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.213401e-01 | 0.207 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.213401e-01 | 0.207 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.226810e-01 | 0.206 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.248861e-01 | 0.204 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.256880e-01 | 0.204 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.256880e-01 | 0.204 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.256880e-01 | 0.204 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.270820e-01 | 0.203 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.270820e-01 | 0.203 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.270820e-01 | 0.203 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.270820e-01 | 0.203 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.270820e-01 | 0.203 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.270820e-01 | 0.203 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.270820e-01 | 0.203 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.270820e-01 | 0.203 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.270820e-01 | 0.203 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.270820e-01 | 0.203 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 6.270820e-01 | 0.203 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.270820e-01 | 0.203 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.270820e-01 | 0.203 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.270820e-01 | 0.203 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.270820e-01 | 0.203 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.270820e-01 | 0.203 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 6.270820e-01 | 0.203 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.270820e-01 | 0.203 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.270820e-01 | 0.203 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.270820e-01 | 0.203 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.270820e-01 | 0.203 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.270820e-01 | 0.203 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.289314e-01 | 0.201 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.293789e-01 | 0.201 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.313318e-01 | 0.200 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.313318e-01 | 0.200 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.352334e-01 | 0.197 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.361395e-01 | 0.196 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.361395e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.361395e-01 | 0.196 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.432959e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.464390e-01 | 0.189 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.464390e-01 | 0.189 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.469324e-01 | 0.189 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.473581e-01 | 0.189 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.473581e-01 | 0.189 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.473581e-01 | 0.189 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.501636e-01 | 0.187 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.501636e-01 | 0.187 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.501636e-01 | 0.187 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.536860e-01 | 0.185 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.536860e-01 | 0.185 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.681797e-01 | 0.175 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.687604e-01 | 0.175 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.691282e-01 | 0.174 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.691282e-01 | 0.174 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.701719e-01 | 0.174 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.703333e-01 | 0.174 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.703333e-01 | 0.174 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.703333e-01 | 0.174 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.703333e-01 | 0.174 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.703333e-01 | 0.174 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.703333e-01 | 0.174 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.703333e-01 | 0.174 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.703333e-01 | 0.174 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.703523e-01 | 0.174 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.703523e-01 | 0.174 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.703523e-01 | 0.174 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.703523e-01 | 0.174 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 6.703523e-01 | 0.174 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.703523e-01 | 0.174 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.703523e-01 | 0.174 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.703523e-01 | 0.174 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.703523e-01 | 0.174 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.703523e-01 | 0.174 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.703523e-01 | 0.174 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.703523e-01 | 0.174 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.703523e-01 | 0.174 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.703523e-01 | 0.174 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.703523e-01 | 0.174 | 0 | 0 |
| Agmatine biosynthesis | R-HSA-351143 | 6.703523e-01 | 0.174 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.703523e-01 | 0.174 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.707018e-01 | 0.173 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.707018e-01 | 0.173 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.707018e-01 | 0.173 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.707018e-01 | 0.173 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.764751e-01 | 0.170 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.789194e-01 | 0.168 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.789194e-01 | 0.168 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.789194e-01 | 0.168 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.789194e-01 | 0.168 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.789194e-01 | 0.168 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.789194e-01 | 0.168 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.789194e-01 | 0.168 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.789194e-01 | 0.168 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.789194e-01 | 0.168 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.789194e-01 | 0.168 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.789194e-01 | 0.168 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.789194e-01 | 0.168 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.825792e-01 | 0.166 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.871751e-01 | 0.163 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.881408e-01 | 0.162 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.881408e-01 | 0.162 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.886435e-01 | 0.162 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.930204e-01 | 0.159 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.930204e-01 | 0.159 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.930204e-01 | 0.159 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.930204e-01 | 0.159 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.930204e-01 | 0.159 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.936502e-01 | 0.159 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.009317e-01 | 0.154 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.009317e-01 | 0.154 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.034407e-01 | 0.153 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.040613e-01 | 0.152 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.057145e-01 | 0.151 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.057145e-01 | 0.151 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.057145e-01 | 0.151 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.057145e-01 | 0.151 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.057145e-01 | 0.151 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.057145e-01 | 0.151 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.063047e-01 | 0.151 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.072360e-01 | 0.150 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.086041e-01 | 0.150 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.086041e-01 | 0.150 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.086041e-01 | 0.150 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.086041e-01 | 0.150 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.086041e-01 | 0.150 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.086041e-01 | 0.150 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.086041e-01 | 0.150 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.086041e-01 | 0.150 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.086041e-01 | 0.150 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.086041e-01 | 0.150 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.086041e-01 | 0.150 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.086041e-01 | 0.150 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.086041e-01 | 0.150 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.106677e-01 | 0.148 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.145081e-01 | 0.146 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.145081e-01 | 0.146 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.153552e-01 | 0.145 | 1 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.161465e-01 | 0.145 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.172785e-01 | 0.144 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.177659e-01 | 0.144 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.184626e-01 | 0.144 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.203275e-01 | 0.142 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.206961e-01 | 0.142 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.206961e-01 | 0.142 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.206961e-01 | 0.142 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.206961e-01 | 0.142 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.233479e-01 | 0.141 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.254658e-01 | 0.139 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.254658e-01 | 0.139 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.285097e-01 | 0.138 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.285097e-01 | 0.138 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.306168e-01 | 0.136 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.306168e-01 | 0.136 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.316151e-01 | 0.136 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.316151e-01 | 0.136 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.316151e-01 | 0.136 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.316151e-01 | 0.136 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.316151e-01 | 0.136 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.348129e-01 | 0.134 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.348129e-01 | 0.134 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.348129e-01 | 0.134 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.348129e-01 | 0.134 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.348129e-01 | 0.134 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.424192e-01 | 0.129 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.424192e-01 | 0.129 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.424192e-01 | 0.129 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.424192e-01 | 0.129 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.424192e-01 | 0.129 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.424192e-01 | 0.129 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.424192e-01 | 0.129 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.424192e-01 | 0.129 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.424192e-01 | 0.129 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.424192e-01 | 0.129 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.424192e-01 | 0.129 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.424192e-01 | 0.129 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.424192e-01 | 0.129 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.424192e-01 | 0.129 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.424192e-01 | 0.129 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.424192e-01 | 0.129 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 7.424192e-01 | 0.129 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.428359e-01 | 0.129 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.428359e-01 | 0.129 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.428618e-01 | 0.129 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.437196e-01 | 0.129 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.449864e-01 | 0.128 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.475127e-01 | 0.126 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.475127e-01 | 0.126 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.519306e-01 | 0.124 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.537046e-01 | 0.123 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.537046e-01 | 0.123 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.537046e-01 | 0.123 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.537046e-01 | 0.123 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.539585e-01 | 0.123 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.539585e-01 | 0.123 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.549291e-01 | 0.122 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.554447e-01 | 0.122 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.554447e-01 | 0.122 | 1 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.563464e-01 | 0.121 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.578798e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.593563e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.593563e-01 | 0.120 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.611987e-01 | 0.119 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.677136e-01 | 0.115 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.702968e-01 | 0.113 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.719746e-01 | 0.112 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.719746e-01 | 0.112 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.719746e-01 | 0.112 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.723120e-01 | 0.112 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.723120e-01 | 0.112 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.723120e-01 | 0.112 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.723120e-01 | 0.112 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.723120e-01 | 0.112 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.723120e-01 | 0.112 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.723120e-01 | 0.112 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.723120e-01 | 0.112 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.723120e-01 | 0.112 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.723120e-01 | 0.112 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.723120e-01 | 0.112 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.743299e-01 | 0.111 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.750637e-01 | 0.111 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.750637e-01 | 0.111 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.804839e-01 | 0.108 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.804839e-01 | 0.108 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.804839e-01 | 0.108 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.841254e-01 | 0.106 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.888957e-01 | 0.103 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.888957e-01 | 0.103 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.888957e-01 | 0.103 | 1 | 1 |
| Inflammasomes | R-HSA-622312 | 7.888957e-01 | 0.103 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.899080e-01 | 0.102 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.918848e-01 | 0.101 | 1 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.947842e-01 | 0.100 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.947842e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.947842e-01 | 0.100 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.947842e-01 | 0.100 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.987372e-01 | 0.098 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.987372e-01 | 0.098 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.987372e-01 | 0.098 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.987372e-01 | 0.098 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.987372e-01 | 0.098 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.987372e-01 | 0.098 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.989523e-01 | 0.097 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.020875e-01 | 0.096 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.039769e-01 | 0.095 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.047597e-01 | 0.094 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.047597e-01 | 0.094 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.047597e-01 | 0.094 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.047597e-01 | 0.094 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.047597e-01 | 0.094 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.064313e-01 | 0.093 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.086688e-01 | 0.092 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.101995e-01 | 0.091 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.107451e-01 | 0.091 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.129587e-01 | 0.090 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.129587e-01 | 0.090 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.147747e-01 | 0.089 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.159428e-01 | 0.088 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.167307e-01 | 0.088 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.168145e-01 | 0.088 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.172704e-01 | 0.088 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.172704e-01 | 0.088 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.172704e-01 | 0.088 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.184604e-01 | 0.087 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.196077e-01 | 0.086 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.196077e-01 | 0.086 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.204935e-01 | 0.086 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.214282e-01 | 0.085 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.220969e-01 | 0.085 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.220969e-01 | 0.085 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.220969e-01 | 0.085 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.220969e-01 | 0.085 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.220969e-01 | 0.085 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.220969e-01 | 0.085 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.220969e-01 | 0.085 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.220969e-01 | 0.085 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.220969e-01 | 0.085 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.220969e-01 | 0.085 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.253897e-01 | 0.083 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.296804e-01 | 0.081 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 8.296804e-01 | 0.081 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.298131e-01 | 0.081 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.298131e-01 | 0.081 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.298131e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.298131e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.298131e-01 | 0.081 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.298806e-01 | 0.081 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.298806e-01 | 0.081 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.312449e-01 | 0.080 | 1 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.334826e-01 | 0.079 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.368246e-01 | 0.077 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.407090e-01 | 0.075 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.418948e-01 | 0.075 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.427465e-01 | 0.074 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.427465e-01 | 0.074 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.427465e-01 | 0.074 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.427465e-01 | 0.074 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.427465e-01 | 0.074 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.427465e-01 | 0.074 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.427465e-01 | 0.074 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.427465e-01 | 0.074 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.427465e-01 | 0.074 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.427465e-01 | 0.074 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.441704e-01 | 0.074 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.442949e-01 | 0.074 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.450416e-01 | 0.073 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.450416e-01 | 0.073 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.450416e-01 | 0.073 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.464285e-01 | 0.072 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.509638e-01 | 0.070 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.527505e-01 | 0.069 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.527505e-01 | 0.069 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.584904e-01 | 0.066 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.584904e-01 | 0.066 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.586588e-01 | 0.066 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.591328e-01 | 0.066 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.591328e-01 | 0.066 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 8.591328e-01 | 0.066 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.591328e-01 | 0.066 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.606639e-01 | 0.065 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.610003e-01 | 0.065 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.610003e-01 | 0.065 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.610003e-01 | 0.065 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.610003e-01 | 0.065 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.610003e-01 | 0.065 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.610003e-01 | 0.065 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.610003e-01 | 0.065 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.610003e-01 | 0.065 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.632001e-01 | 0.064 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.632001e-01 | 0.064 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.632001e-01 | 0.064 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.688880e-01 | 0.061 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.697134e-01 | 0.061 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.697134e-01 | 0.061 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.697134e-01 | 0.061 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.698290e-01 | 0.061 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.720417e-01 | 0.059 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.720417e-01 | 0.059 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.755705e-01 | 0.058 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.760457e-01 | 0.057 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.768489e-01 | 0.057 | 1 | 1 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 8.771362e-01 | 0.057 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.771362e-01 | 0.057 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.771362e-01 | 0.057 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.771362e-01 | 0.057 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.771362e-01 | 0.057 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.771362e-01 | 0.057 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.771362e-01 | 0.057 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.771362e-01 | 0.057 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.801424e-01 | 0.055 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.801424e-01 | 0.055 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.801424e-01 | 0.055 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.801424e-01 | 0.055 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.801424e-01 | 0.055 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.819482e-01 | 0.055 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.822021e-01 | 0.054 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.822021e-01 | 0.054 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.838529e-01 | 0.054 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.847724e-01 | 0.053 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.866340e-01 | 0.052 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.891080e-01 | 0.051 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.902793e-01 | 0.050 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.908116e-01 | 0.050 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.908116e-01 | 0.050 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.908116e-01 | 0.050 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.913998e-01 | 0.050 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.913998e-01 | 0.050 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.913998e-01 | 0.050 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.913998e-01 | 0.050 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.913998e-01 | 0.050 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.913998e-01 | 0.050 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.913998e-01 | 0.050 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.913998e-01 | 0.050 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.913998e-01 | 0.050 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.913998e-01 | 0.050 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.913998e-01 | 0.050 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.913998e-01 | 0.050 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.913998e-01 | 0.050 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.946473e-01 | 0.048 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.946473e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.946473e-01 | 0.048 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.946473e-01 | 0.048 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.946473e-01 | 0.048 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.987946e-01 | 0.046 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.987946e-01 | 0.046 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.987946e-01 | 0.046 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.987946e-01 | 0.046 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.988647e-01 | 0.046 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.036558e-01 | 0.044 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.040082e-01 | 0.044 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.040082e-01 | 0.044 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.040082e-01 | 0.044 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.040082e-01 | 0.044 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.040082e-01 | 0.044 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.040429e-01 | 0.044 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.045017e-01 | 0.044 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.045017e-01 | 0.044 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.045017e-01 | 0.044 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.071035e-01 | 0.042 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.093424e-01 | 0.041 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.115914e-01 | 0.040 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.131239e-01 | 0.039 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.134132e-01 | 0.039 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.134887e-01 | 0.039 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.134887e-01 | 0.039 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.136646e-01 | 0.039 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.143333e-01 | 0.039 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.147127e-01 | 0.039 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.147127e-01 | 0.039 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.147892e-01 | 0.039 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.147892e-01 | 0.039 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.149496e-01 | 0.039 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.151535e-01 | 0.039 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.151535e-01 | 0.039 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.151535e-01 | 0.039 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.151535e-01 | 0.039 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.151535e-01 | 0.039 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.151535e-01 | 0.039 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.152865e-01 | 0.038 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.152865e-01 | 0.038 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.152865e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.192934e-01 | 0.037 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.199629e-01 | 0.036 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.206690e-01 | 0.036 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.206975e-01 | 0.036 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.207558e-01 | 0.036 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.216770e-01 | 0.035 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.216770e-01 | 0.035 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.228408e-01 | 0.035 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.250053e-01 | 0.034 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.250053e-01 | 0.034 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.250053e-01 | 0.034 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.250053e-01 | 0.034 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.250053e-01 | 0.034 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.250053e-01 | 0.034 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.250053e-01 | 0.034 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.250053e-01 | 0.034 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.250053e-01 | 0.034 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.284478e-01 | 0.032 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.284478e-01 | 0.032 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.284478e-01 | 0.032 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.284478e-01 | 0.032 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.287232e-01 | 0.032 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.304404e-01 | 0.031 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.324613e-01 | 0.030 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.328143e-01 | 0.030 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.337136e-01 | 0.030 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.337136e-01 | 0.030 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.337136e-01 | 0.030 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.337136e-01 | 0.030 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.337136e-01 | 0.030 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.344948e-01 | 0.029 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.344948e-01 | 0.029 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.358785e-01 | 0.029 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.359102e-01 | 0.029 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.365512e-01 | 0.028 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.368320e-01 | 0.028 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.373594e-01 | 0.028 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.398784e-01 | 0.027 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.400671e-01 | 0.027 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.400671e-01 | 0.027 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.410771e-01 | 0.026 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.414113e-01 | 0.026 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.414113e-01 | 0.026 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.414113e-01 | 0.026 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.420713e-01 | 0.026 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.420713e-01 | 0.026 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.420713e-01 | 0.026 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.437235e-01 | 0.025 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.464901e-01 | 0.024 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.476663e-01 | 0.023 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.476663e-01 | 0.023 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.482154e-01 | 0.023 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.482154e-01 | 0.023 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.482154e-01 | 0.023 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.482154e-01 | 0.023 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.482154e-01 | 0.023 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.490759e-01 | 0.023 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.493832e-01 | 0.023 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.499168e-01 | 0.022 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.516136e-01 | 0.022 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.527435e-01 | 0.021 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.527435e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.531245e-01 | 0.021 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.531245e-01 | 0.021 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.542296e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.542296e-01 | 0.020 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.542296e-01 | 0.020 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.542296e-01 | 0.020 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.542550e-01 | 0.020 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.549858e-01 | 0.020 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.566041e-01 | 0.019 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.566373e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.573476e-01 | 0.019 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.573476e-01 | 0.019 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.573476e-01 | 0.019 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.582396e-01 | 0.019 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.582396e-01 | 0.019 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.582396e-01 | 0.019 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.588547e-01 | 0.018 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.595457e-01 | 0.018 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.595457e-01 | 0.018 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.595457e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.595457e-01 | 0.018 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.595457e-01 | 0.018 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.595457e-01 | 0.018 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.595457e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.595457e-01 | 0.018 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.595457e-01 | 0.018 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.603401e-01 | 0.018 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.603401e-01 | 0.018 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.605185e-01 | 0.017 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.615201e-01 | 0.017 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.615201e-01 | 0.017 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.615201e-01 | 0.017 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.615201e-01 | 0.017 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.615201e-01 | 0.017 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.615201e-01 | 0.017 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.615201e-01 | 0.017 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.616216e-01 | 0.017 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.618968e-01 | 0.017 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.618968e-01 | 0.017 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.628857e-01 | 0.016 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.628857e-01 | 0.016 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.631380e-01 | 0.016 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.642446e-01 | 0.016 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.642446e-01 | 0.016 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.642446e-01 | 0.016 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.642446e-01 | 0.016 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.642446e-01 | 0.016 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.642446e-01 | 0.016 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.652511e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.652991e-01 | 0.015 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.652991e-01 | 0.015 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.652991e-01 | 0.015 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.652991e-01 | 0.015 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.656783e-01 | 0.015 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.669955e-01 | 0.015 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.672503e-01 | 0.014 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.674245e-01 | 0.014 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.675991e-01 | 0.014 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.681763e-01 | 0.014 | 1 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.682221e-01 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.682221e-01 | 0.014 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.683255e-01 | 0.014 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.683980e-01 | 0.014 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.683980e-01 | 0.014 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.683980e-01 | 0.014 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.683980e-01 | 0.014 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.687197e-01 | 0.014 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.687197e-01 | 0.014 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.702510e-01 | 0.013 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.711415e-01 | 0.013 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.716285e-01 | 0.012 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.718141e-01 | 0.012 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.719177e-01 | 0.012 | 1 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.720691e-01 | 0.012 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.720691e-01 | 0.012 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.720691e-01 | 0.012 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.720691e-01 | 0.012 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.730017e-01 | 0.012 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.736034e-01 | 0.012 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.746119e-01 | 0.011 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.746119e-01 | 0.011 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.746119e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.753140e-01 | 0.011 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.753140e-01 | 0.011 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.753140e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.753140e-01 | 0.011 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.753140e-01 | 0.011 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.754425e-01 | 0.011 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.754900e-01 | 0.011 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.760772e-01 | 0.011 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.760772e-01 | 0.011 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.771403e-01 | 0.010 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.771403e-01 | 0.010 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.771403e-01 | 0.010 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.781820e-01 | 0.010 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.789568e-01 | 0.009 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.794240e-01 | 0.009 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.794240e-01 | 0.009 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.794240e-01 | 0.009 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.802990e-01 | 0.009 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.807170e-01 | 0.008 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.807170e-01 | 0.008 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.807170e-01 | 0.008 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.807170e-01 | 0.008 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.807170e-01 | 0.008 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.807170e-01 | 0.008 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.807170e-01 | 0.008 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.814859e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.823544e-01 | 0.008 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.829576e-01 | 0.007 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.829576e-01 | 0.007 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.829576e-01 | 0.007 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.829576e-01 | 0.007 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.829576e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.833466e-01 | 0.007 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.833466e-01 | 0.007 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.836443e-01 | 0.007 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.849252e-01 | 0.007 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.849379e-01 | 0.007 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.849379e-01 | 0.007 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.851423e-01 | 0.007 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.859784e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.859784e-01 | 0.006 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.865382e-01 | 0.006 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.866883e-01 | 0.006 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.866883e-01 | 0.006 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.866883e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.867089e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.876408e-01 | 0.005 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.879022e-01 | 0.005 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.879022e-01 | 0.005 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.879022e-01 | 0.005 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.879022e-01 | 0.005 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.879521e-01 | 0.005 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.882353e-01 | 0.005 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.882353e-01 | 0.005 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.888871e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.888871e-01 | 0.005 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.896026e-01 | 0.005 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.899196e-01 | 0.004 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.902377e-01 | 0.004 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.908593e-01 | 0.004 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.913025e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.914764e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.917142e-01 | 0.004 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.918791e-01 | 0.004 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.922989e-01 | 0.003 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.928231e-01 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.928231e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.928402e-01 | 0.003 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.934708e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.934708e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.936574e-01 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.936574e-01 | 0.003 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.936574e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.941179e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.943155e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.943155e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.943948e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.950235e-01 | 0.002 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.950465e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.950465e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.954330e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.956224e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.956224e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.956224e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.958304e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.958304e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.961314e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.961314e-01 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.962722e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.963273e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.965109e-01 | 0.002 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.965765e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.965813e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.965813e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.969475e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.969788e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.972663e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.973302e-01 | 0.001 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.973302e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.976349e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.977497e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.980173e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.981042e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.982608e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.983447e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.983719e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.985332e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.985613e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.985617e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.986992e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.987287e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.988766e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.989295e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.989861e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.990276e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.990292e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.991228e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.992249e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.992249e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.993151e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.993789e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.993883e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.994137e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.994160e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.994284e-01 | 0.000 | 1 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.994626e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.994652e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.995090e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.995595e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.995825e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995838e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.996041e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.996740e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.996830e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.997180e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.997455e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.997658e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.998013e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.998013e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998168e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998281e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998449e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998630e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.998654e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998671e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.998725e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998987e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999135e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999424e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999424e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999424e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999424e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.999546e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999551e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999570e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999601e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999603e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999636e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999649e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999674e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999707e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999745e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999758e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999786e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999797e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999833e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999837e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999844e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999844e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999860e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999865e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999885e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999950e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999951e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999952e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999955e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999957e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999965e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999971e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999980e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999980e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999981e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999990e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999991e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999994e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999994e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 1 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 1 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 1 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.187939e-14 | 13.925 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.120526e-14 | 13.674 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.209655e-13 | 12.494 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.934686e-11 | 10.003 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.986603e-10 | 9.525 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.398238e-09 | 8.854 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.780236e-09 | 8.750 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.388075e-09 | 8.622 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.019159e-09 | 8.299 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.103027e-09 | 8.214 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.181626e-09 | 8.144 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.012335e-09 | 8.096 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.549047e-09 | 8.020 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.492316e-09 | 8.023 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.240666e-08 | 7.906 | 1 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.491058e-08 | 7.827 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.557846e-08 | 7.807 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.784715e-08 | 7.555 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.817852e-08 | 7.550 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.272801e-08 | 7.369 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.321692e-08 | 7.199 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.455491e-08 | 7.190 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.595641e-08 | 7.018 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.595641e-08 | 7.018 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.264272e-07 | 6.898 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.354867e-07 | 6.868 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.320702e-07 | 6.879 | 1 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.483193e-07 | 6.829 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.580077e-07 | 6.588 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.032832e-07 | 6.394 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.955978e-07 | 6.403 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.554915e-07 | 6.342 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.118667e-07 | 6.291 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.362961e-07 | 6.271 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.361750e-07 | 6.196 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.706232e-07 | 6.174 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.860810e-07 | 6.105 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.860810e-07 | 6.105 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.289915e-07 | 6.081 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.692630e-07 | 6.061 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.082204e-07 | 6.042 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.044644e-06 | 5.981 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.213439e-06 | 5.916 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.316682e-06 | 5.881 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.311464e-06 | 5.882 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.540303e-06 | 5.812 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.501549e-06 | 5.823 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.586281e-06 | 5.800 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.840545e-06 | 5.735 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.946035e-06 | 5.711 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.974010e-06 | 5.705 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.183139e-06 | 5.661 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.286070e-06 | 5.641 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.286070e-06 | 5.641 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.463072e-06 | 5.609 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.227603e-06 | 5.491 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.599243e-06 | 5.337 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.959062e-06 | 5.305 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.838403e-06 | 5.315 | 1 | 1 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.251182e-06 | 5.280 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.787505e-06 | 5.238 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.787505e-06 | 5.238 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.420977e-06 | 5.192 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.249367e-06 | 5.140 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.544227e-06 | 5.122 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.725833e-06 | 5.112 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.916170e-06 | 5.050 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.071653e-05 | 4.970 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.171332e-05 | 4.931 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.240661e-05 | 4.906 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.279775e-05 | 4.893 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.347140e-05 | 4.871 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.499999e-05 | 4.824 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.484325e-05 | 4.828 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.529281e-05 | 4.816 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.671848e-05 | 4.777 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.611017e-05 | 4.793 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.671848e-05 | 4.777 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.800741e-05 | 4.745 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.800741e-05 | 4.745 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.088868e-05 | 4.680 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.063407e-05 | 4.685 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.621790e-05 | 4.581 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.867009e-05 | 4.543 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.867009e-05 | 4.543 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.873379e-05 | 4.542 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.925532e-05 | 4.534 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.928346e-05 | 4.533 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.173308e-05 | 4.498 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.119127e-05 | 4.506 | 1 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.756582e-05 | 4.425 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.983409e-05 | 4.400 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.042253e-05 | 4.393 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.060185e-05 | 4.391 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.735019e-05 | 4.325 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.566740e-05 | 4.340 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.777868e-05 | 4.321 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.130137e-05 | 4.290 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.743580e-05 | 4.241 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.784128e-05 | 4.238 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.636330e-05 | 4.178 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.795705e-05 | 4.168 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.052380e-05 | 4.152 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.052380e-05 | 4.152 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.621147e-05 | 4.118 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.781403e-05 | 4.109 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.503365e-05 | 4.125 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.621147e-05 | 4.118 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.279395e-05 | 4.138 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.242060e-05 | 4.084 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.220576e-05 | 4.085 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.220576e-05 | 4.085 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.030920e-05 | 4.095 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.004144e-05 | 4.097 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.496618e-05 | 4.071 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.030920e-05 | 4.095 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.030920e-05 | 4.095 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.768393e-05 | 4.057 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.355595e-05 | 4.029 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.087620e-04 | 3.964 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.213174e-04 | 3.916 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.354480e-04 | 3.868 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.354480e-04 | 3.868 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.274096e-04 | 3.895 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.327517e-04 | 3.877 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.308671e-04 | 3.883 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.359497e-04 | 3.867 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.428568e-04 | 3.845 | 1 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.474744e-04 | 3.831 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.567624e-04 | 3.805 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.714687e-04 | 3.766 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.714687e-04 | 3.766 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.703771e-04 | 3.769 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.686580e-04 | 3.773 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.645837e-04 | 3.784 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.709118e-04 | 3.767 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.578670e-04 | 3.802 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.798210e-04 | 3.745 | 1 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.834443e-04 | 3.736 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.889572e-04 | 3.724 | 1 | 1 |
| Meiosis | R-HSA-1500620 | 1.898755e-04 | 3.722 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.063390e-04 | 3.685 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.241178e-04 | 3.650 | 1 | 1 |
| CaM pathway | R-HSA-111997 | 2.176663e-04 | 3.662 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.176663e-04 | 3.662 | 1 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.176663e-04 | 3.662 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.289130e-04 | 3.640 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.188331e-04 | 3.660 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.363784e-04 | 3.626 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.547414e-04 | 3.594 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.703742e-04 | 3.568 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.738634e-04 | 3.562 | 1 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.899968e-04 | 3.538 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.012141e-04 | 3.521 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.133890e-04 | 3.504 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.293726e-04 | 3.482 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.141936e-04 | 3.503 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.968957e-04 | 3.527 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.139337e-04 | 3.503 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.226349e-04 | 3.491 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.054139e-04 | 3.515 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.285402e-04 | 3.483 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.327972e-04 | 3.478 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.557548e-04 | 3.449 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.572819e-04 | 3.447 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.621202e-04 | 3.441 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.901220e-04 | 3.409 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.090336e-04 | 3.388 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.090336e-04 | 3.388 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.090336e-04 | 3.388 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.094864e-04 | 3.388 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.206654e-04 | 3.376 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.246228e-04 | 3.372 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.257264e-04 | 3.371 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.290145e-04 | 3.368 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.837364e-04 | 3.315 | 1 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.747642e-04 | 3.324 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.580198e-04 | 3.339 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.842279e-04 | 3.315 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.878531e-04 | 3.312 | 1 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.903287e-04 | 3.310 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.964994e-04 | 3.304 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.984568e-04 | 3.302 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.984568e-04 | 3.302 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.334966e-04 | 3.273 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.426646e-04 | 3.265 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.788498e-04 | 3.237 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.788498e-04 | 3.237 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.788498e-04 | 3.237 | 1 | 1 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.788498e-04 | 3.237 | 1 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.858448e-04 | 3.232 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.858448e-04 | 3.232 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.880470e-04 | 3.231 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.943730e-04 | 3.226 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.943730e-04 | 3.226 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.038974e-04 | 3.219 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.354159e-04 | 3.197 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.835810e-04 | 3.165 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.755726e-04 | 3.110 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.729829e-04 | 3.112 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.949006e-04 | 3.100 | 1 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.245427e-04 | 3.140 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.155891e-04 | 3.089 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.155891e-04 | 3.089 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.155891e-04 | 3.089 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.155891e-04 | 3.089 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.242194e-04 | 3.084 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.078110e-04 | 3.042 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.078110e-04 | 3.042 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.542777e-04 | 3.020 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.647831e-04 | 3.016 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.002720e-03 | 2.999 | 1 | 1 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.002720e-03 | 2.999 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.096102e-03 | 2.960 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.121355e-03 | 2.950 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.366720e-03 | 2.864 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.366720e-03 | 2.864 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.390758e-03 | 2.857 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.390758e-03 | 2.857 | 1 | 1 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.390758e-03 | 2.857 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.458933e-03 | 2.836 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.558184e-03 | 2.807 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.654473e-03 | 2.781 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.711144e-03 | 2.767 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.704492e-03 | 2.768 | 1 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.654473e-03 | 2.781 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.570479e-03 | 2.804 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.551262e-03 | 2.809 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.570479e-03 | 2.804 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.654845e-03 | 2.781 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.627030e-03 | 2.789 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.743905e-03 | 2.758 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.839015e-03 | 2.735 | 1 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.864546e-03 | 2.729 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.877301e-03 | 2.726 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.880669e-03 | 2.726 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.916269e-03 | 2.718 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.989889e-03 | 2.701 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.047593e-03 | 2.689 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.047593e-03 | 2.689 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.061087e-03 | 2.686 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.061087e-03 | 2.686 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.351665e-03 | 2.629 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.388621e-03 | 2.622 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.502435e-03 | 2.602 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.502854e-03 | 2.602 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.502854e-03 | 2.602 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.588482e-03 | 2.587 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.588482e-03 | 2.587 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.598948e-03 | 2.585 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.655183e-03 | 2.576 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.716104e-03 | 2.566 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.820229e-03 | 2.550 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.848904e-03 | 2.545 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.045869e-03 | 2.516 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.045869e-03 | 2.516 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.666032e-03 | 2.436 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.810185e-03 | 2.419 | 1 | 1 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.810185e-03 | 2.419 | 1 | 1 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.612994e-03 | 2.442 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.422327e-03 | 2.466 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.529378e-03 | 2.452 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.845560e-03 | 2.415 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.847326e-03 | 2.415 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.340137e-03 | 2.476 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.612994e-03 | 2.442 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.666032e-03 | 2.436 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.851484e-03 | 2.414 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.851484e-03 | 2.414 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.851484e-03 | 2.414 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.134251e-03 | 2.384 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.134251e-03 | 2.384 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.138952e-03 | 2.383 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.138952e-03 | 2.383 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.298114e-03 | 2.367 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.529495e-03 | 2.344 | 1 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.589959e-03 | 2.338 | 1 | 1 |
| Kinesins | R-HSA-983189 | 4.643643e-03 | 2.333 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.009027e-03 | 2.300 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.028211e-03 | 2.299 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.056401e-03 | 2.296 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.138546e-03 | 2.289 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.138546e-03 | 2.289 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.138546e-03 | 2.289 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.138546e-03 | 2.289 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.251486e-03 | 2.280 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.262291e-03 | 2.279 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.507233e-03 | 2.259 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.604638e-03 | 2.251 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.733390e-03 | 2.242 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.733390e-03 | 2.242 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.901771e-03 | 2.229 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.905539e-03 | 2.229 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.187291e-03 | 2.208 | 1 | 1 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.518028e-03 | 2.186 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.577511e-03 | 2.182 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.577511e-03 | 2.182 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 6.577511e-03 | 2.182 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 6.577511e-03 | 2.182 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.658938e-03 | 2.177 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.715656e-03 | 2.173 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.715656e-03 | 2.173 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.816819e-03 | 2.166 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.296329e-03 | 2.137 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.153601e-03 | 2.145 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.430737e-03 | 2.074 | 1 | 1 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.296329e-03 | 2.137 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.008630e-03 | 2.154 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.436109e-03 | 2.074 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.616896e-03 | 2.065 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.760901e-03 | 2.110 | 1 | 1 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.710246e-03 | 2.113 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.751747e-03 | 2.111 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.153601e-03 | 2.145 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.278676e-03 | 2.138 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.874723e-03 | 2.104 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.756761e-03 | 2.110 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.874723e-03 | 2.104 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.093729e-03 | 2.149 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.740235e-03 | 2.111 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.745485e-03 | 2.058 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.818893e-03 | 2.055 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.818893e-03 | 2.055 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.853828e-03 | 2.053 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.397451e-03 | 2.027 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 9.822711e-03 | 2.008 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 9.822711e-03 | 2.008 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.893556e-03 | 2.005 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.005847e-02 | 1.997 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.005847e-02 | 1.997 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.056413e-02 | 1.976 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.065692e-02 | 1.972 | 1 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.071524e-02 | 1.970 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.075214e-02 | 1.969 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.080949e-02 | 1.966 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.087565e-02 | 1.964 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.087565e-02 | 1.964 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.090839e-02 | 1.962 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.092729e-02 | 1.961 | 1 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.114543e-02 | 1.953 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.120194e-02 | 1.951 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.143945e-02 | 1.942 | 1 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.161512e-02 | 1.935 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.161512e-02 | 1.935 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.190845e-02 | 1.924 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.190845e-02 | 1.924 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.229545e-02 | 1.910 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.238615e-02 | 1.907 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.289249e-02 | 1.890 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.289249e-02 | 1.890 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.297583e-02 | 1.887 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.297583e-02 | 1.887 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.303221e-02 | 1.885 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.352409e-02 | 1.869 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.352409e-02 | 1.869 | 0 | 0 |
| Translation | R-HSA-72766 | 1.352496e-02 | 1.869 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.366969e-02 | 1.864 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.367882e-02 | 1.864 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.367882e-02 | 1.864 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.390228e-02 | 1.857 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.394534e-02 | 1.856 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.406245e-02 | 1.852 | 1 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.408780e-02 | 1.851 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.413000e-02 | 1.850 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.413000e-02 | 1.850 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.430482e-02 | 1.845 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.457775e-02 | 1.836 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.460120e-02 | 1.836 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.468732e-02 | 1.833 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.468732e-02 | 1.833 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.468732e-02 | 1.833 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.468732e-02 | 1.833 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.468732e-02 | 1.833 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.468732e-02 | 1.833 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.551186e-02 | 1.809 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.551186e-02 | 1.809 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.553204e-02 | 1.809 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.553204e-02 | 1.809 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.605108e-02 | 1.794 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.605108e-02 | 1.794 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.605108e-02 | 1.794 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.625863e-02 | 1.789 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.625863e-02 | 1.789 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.625863e-02 | 1.789 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.655225e-02 | 1.781 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.655225e-02 | 1.781 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.655225e-02 | 1.781 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.655225e-02 | 1.781 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.796676e-02 | 1.746 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.903388e-02 | 1.720 | 1 | 1 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.010997e-02 | 1.697 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.838121e-02 | 1.736 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.137065e-02 | 1.670 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.395958e-02 | 1.621 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.005378e-02 | 1.698 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.410176e-02 | 1.618 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.878132e-02 | 1.726 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.903388e-02 | 1.720 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.903388e-02 | 1.720 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.900457e-02 | 1.721 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.447161e-02 | 1.611 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.903388e-02 | 1.720 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.146486e-02 | 1.668 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.878132e-02 | 1.726 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.903388e-02 | 1.720 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.277054e-02 | 1.643 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.505378e-02 | 1.601 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.513739e-02 | 1.600 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.513739e-02 | 1.600 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.513739e-02 | 1.600 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.513739e-02 | 1.600 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.519827e-02 | 1.599 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.562007e-02 | 1.591 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.567436e-02 | 1.591 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.570308e-02 | 1.590 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.580116e-02 | 1.588 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.580116e-02 | 1.588 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.580116e-02 | 1.588 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.617570e-02 | 1.582 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.672305e-02 | 1.573 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.692545e-02 | 1.570 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.692545e-02 | 1.570 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.784895e-02 | 1.555 | 1 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.856663e-02 | 1.544 | 1 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.859128e-02 | 1.544 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.865462e-02 | 1.543 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.865462e-02 | 1.543 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.865462e-02 | 1.543 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.918169e-02 | 1.535 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.942370e-02 | 1.531 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.956406e-02 | 1.529 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.066346e-02 | 1.513 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.075050e-02 | 1.512 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.075050e-02 | 1.512 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.113908e-02 | 1.507 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.113908e-02 | 1.507 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.145504e-02 | 1.502 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.145504e-02 | 1.502 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.145504e-02 | 1.502 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.145504e-02 | 1.502 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.183901e-02 | 1.497 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.229386e-02 | 1.491 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.229386e-02 | 1.491 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.356954e-02 | 1.474 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.359870e-02 | 1.474 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.359870e-02 | 1.474 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.411356e-02 | 1.467 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.464061e-02 | 1.460 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.555874e-02 | 1.449 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.555874e-02 | 1.449 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.578204e-02 | 1.446 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.658137e-02 | 1.437 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.658137e-02 | 1.437 | 1 | 1 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.658137e-02 | 1.437 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.763585e-02 | 1.424 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.763585e-02 | 1.424 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.782772e-02 | 1.422 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.782772e-02 | 1.422 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.823158e-02 | 1.418 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.834970e-02 | 1.416 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.893766e-02 | 1.410 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.914095e-02 | 1.407 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.914095e-02 | 1.407 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.914095e-02 | 1.407 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.218782e-02 | 1.282 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.218782e-02 | 1.282 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.218782e-02 | 1.282 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 5.218782e-02 | 1.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.218782e-02 | 1.282 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.218782e-02 | 1.282 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.361126e-02 | 1.360 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.361126e-02 | 1.360 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.361126e-02 | 1.360 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.540921e-02 | 1.256 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.122967e-02 | 1.290 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.286626e-02 | 1.368 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.928662e-02 | 1.307 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.705626e-02 | 1.327 | 1 | 1 |
| Integration of provirus | R-HSA-162592 | 4.983791e-02 | 1.302 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.122967e-02 | 1.290 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.696460e-02 | 1.244 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.361126e-02 | 1.360 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.540921e-02 | 1.256 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.598515e-02 | 1.337 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.544043e-02 | 1.256 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.245452e-02 | 1.372 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.696460e-02 | 1.244 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.555777e-02 | 1.341 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.181501e-02 | 1.286 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.245452e-02 | 1.372 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.497833e-02 | 1.260 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.696460e-02 | 1.244 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.696460e-02 | 1.244 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.971427e-02 | 1.304 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.493537e-02 | 1.347 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.614122e-02 | 1.251 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.971427e-02 | 1.304 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.515675e-02 | 1.258 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.540921e-02 | 1.256 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.030854e-02 | 1.298 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.598515e-02 | 1.337 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.935772e-02 | 1.307 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.306447e-02 | 1.275 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.959530e-02 | 1.305 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.909511e-02 | 1.228 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.909511e-02 | 1.228 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.696460e-02 | 1.244 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.983791e-02 | 1.302 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.895602e-02 | 1.310 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.245452e-02 | 1.372 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.921453e-02 | 1.228 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.957148e-02 | 1.225 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.010544e-02 | 1.221 | 1 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.022471e-02 | 1.220 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.022471e-02 | 1.220 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.022471e-02 | 1.220 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.022471e-02 | 1.220 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.124769e-02 | 1.213 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.124769e-02 | 1.213 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.138760e-02 | 1.212 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.138760e-02 | 1.212 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.138760e-02 | 1.212 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.138760e-02 | 1.212 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.143008e-02 | 1.212 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.198456e-02 | 1.208 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.198456e-02 | 1.208 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.243349e-02 | 1.205 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.283569e-02 | 1.202 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.283569e-02 | 1.202 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.382015e-02 | 1.195 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.452204e-02 | 1.190 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.452204e-02 | 1.190 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.613010e-02 | 1.180 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.653279e-02 | 1.177 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.687776e-02 | 1.175 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.901606e-02 | 1.161 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.920568e-02 | 1.160 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.920568e-02 | 1.160 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.029847e-02 | 1.153 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.029847e-02 | 1.153 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.073240e-02 | 1.150 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.210042e-02 | 1.142 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.210042e-02 | 1.142 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.329990e-02 | 1.135 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.436415e-02 | 1.129 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.522845e-02 | 1.124 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.595690e-02 | 1.119 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.595690e-02 | 1.119 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.650492e-02 | 1.116 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.650492e-02 | 1.116 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.663714e-02 | 1.116 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.670160e-02 | 1.115 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.670160e-02 | 1.115 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 7.690998e-02 | 1.114 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.050144e-02 | 1.094 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.050144e-02 | 1.094 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.050144e-02 | 1.094 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.081314e-02 | 1.093 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.081314e-02 | 1.093 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.199209e-02 | 1.086 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.204094e-02 | 1.086 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.410844e-02 | 1.075 | 1 | 1 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.414354e-02 | 1.075 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.414354e-02 | 1.075 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.445026e-02 | 1.073 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.445026e-02 | 1.073 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.445026e-02 | 1.073 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.445026e-02 | 1.073 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.529936e-02 | 1.069 | 1 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.569737e-02 | 1.067 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.702042e-02 | 1.060 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.860669e-02 | 1.053 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.060401e-02 | 1.043 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.161548e-02 | 1.038 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.284905e-02 | 1.032 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.284905e-02 | 1.032 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.284905e-02 | 1.032 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.284905e-02 | 1.032 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.465580e-02 | 1.024 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.757368e-02 | 1.011 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.757368e-02 | 1.011 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.757368e-02 | 1.011 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.757368e-02 | 1.011 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.757368e-02 | 1.011 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.800368e-02 | 1.009 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.800368e-02 | 1.009 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.800368e-02 | 1.009 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.800368e-02 | 1.009 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.855545e-02 | 1.006 | 1 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.898593e-02 | 1.004 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.016963e-01 | 0.993 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.031200e-01 | 0.987 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.036365e-01 | 0.984 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.045077e-01 | 0.981 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.045077e-01 | 0.981 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.045077e-01 | 0.981 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.052004e-01 | 0.978 | 1 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.053264e-01 | 0.977 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.054473e-01 | 0.977 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.056784e-01 | 0.976 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.067646e-01 | 0.972 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.067646e-01 | 0.972 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.094296e-01 | 0.961 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.098244e-01 | 0.959 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.098244e-01 | 0.959 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.109849e-01 | 0.955 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.109849e-01 | 0.955 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.119505e-01 | 0.951 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.121567e-01 | 0.950 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.124026e-01 | 0.949 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.141915e-01 | 0.942 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.153027e-01 | 0.938 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.154025e-01 | 0.938 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.166748e-01 | 0.933 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.168851e-01 | 0.932 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.168851e-01 | 0.932 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.168851e-01 | 0.932 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.168851e-01 | 0.932 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.190539e-01 | 0.924 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.190539e-01 | 0.924 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.190539e-01 | 0.924 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.218924e-01 | 0.914 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.228740e-01 | 0.911 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.244039e-01 | 0.905 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.252658e-01 | 0.902 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.252658e-01 | 0.902 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.272030e-01 | 0.896 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.272030e-01 | 0.896 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.272030e-01 | 0.896 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.272030e-01 | 0.896 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.281354e-01 | 0.892 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.281354e-01 | 0.892 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.312373e-01 | 0.882 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.337613e-01 | 0.874 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.342426e-01 | 0.872 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.342941e-01 | 0.872 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.342941e-01 | 0.872 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.342941e-01 | 0.872 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.349535e-01 | 0.870 | 1 | 1 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.664730e-01 | 0.779 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.664730e-01 | 0.779 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.664730e-01 | 0.779 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.664730e-01 | 0.779 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.664730e-01 | 0.779 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.390155e-01 | 0.622 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.390155e-01 | 0.622 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.390155e-01 | 0.622 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.390155e-01 | 0.622 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.656799e-01 | 0.781 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.656799e-01 | 0.781 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.981616e-01 | 0.703 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.981616e-01 | 0.703 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.981616e-01 | 0.703 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.981616e-01 | 0.703 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.981616e-01 | 0.703 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.581775e-01 | 0.801 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.313111e-01 | 0.636 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.313111e-01 | 0.636 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.313111e-01 | 0.636 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.313111e-01 | 0.636 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.313111e-01 | 0.636 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.802792e-01 | 0.744 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.432691e-01 | 0.844 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.432691e-01 | 0.844 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.432691e-01 | 0.844 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.647667e-01 | 0.577 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 2.647667e-01 | 0.577 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.647667e-01 | 0.577 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.031480e-01 | 0.692 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.600827e-01 | 0.796 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.600827e-01 | 0.796 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.415862e-01 | 0.849 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.506049e-01 | 0.601 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.434658e-01 | 0.843 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.168057e-01 | 0.664 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.528825e-01 | 0.597 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.528825e-01 | 0.597 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.331542e-01 | 0.632 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.726842e-01 | 0.564 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.498361e-01 | 0.602 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.005658e-01 | 0.698 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.719028e-01 | 0.566 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.541669e-01 | 0.595 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.488976e-01 | 0.827 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.523491e-01 | 0.817 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.488976e-01 | 0.827 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.535073e-01 | 0.814 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.501552e-01 | 0.823 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.600757e-01 | 0.585 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.457922e-01 | 0.836 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.457922e-01 | 0.836 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.457922e-01 | 0.836 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.794144e-01 | 0.746 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.528825e-01 | 0.597 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 1.656799e-01 | 0.781 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.528825e-01 | 0.597 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.627938e-01 | 0.788 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.802792e-01 | 0.744 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.726842e-01 | 0.564 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.124374e-01 | 0.673 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.701999e-01 | 0.769 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.600827e-01 | 0.796 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.656799e-01 | 0.781 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.506049e-01 | 0.601 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.636770e-01 | 0.786 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.888673e-01 | 0.724 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.244390e-01 | 0.649 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.802792e-01 | 0.744 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.031480e-01 | 0.692 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.701999e-01 | 0.769 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.656799e-01 | 0.781 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.313111e-01 | 0.636 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.956726e-01 | 0.708 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.368413e-01 | 0.864 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.981616e-01 | 0.703 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.488976e-01 | 0.827 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.874048e-01 | 0.727 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.155500e-01 | 0.666 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.763805e-01 | 0.754 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.956726e-01 | 0.708 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.005658e-01 | 0.698 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.743616e-01 | 0.759 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.664730e-01 | 0.779 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 2.313111e-01 | 0.636 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.432691e-01 | 0.844 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.874048e-01 | 0.727 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.506049e-01 | 0.601 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.205715e-01 | 0.656 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.309564e-01 | 0.636 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.299660e-01 | 0.638 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.535073e-01 | 0.814 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.371154e-01 | 0.625 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.520747e-01 | 0.598 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.657572e-01 | 0.576 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.636770e-01 | 0.786 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.535073e-01 | 0.814 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.535073e-01 | 0.814 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.313111e-01 | 0.636 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.110721e-01 | 0.676 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.313111e-01 | 0.636 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.008348e-01 | 0.697 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.124374e-01 | 0.673 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.415862e-01 | 0.849 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.855382e-01 | 0.732 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.008348e-01 | 0.697 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.168057e-01 | 0.664 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.596498e-01 | 0.586 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.596498e-01 | 0.586 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.847069e-01 | 0.734 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.145891e-01 | 0.668 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.528825e-01 | 0.597 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.827533e-01 | 0.738 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.488976e-01 | 0.827 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.981616e-01 | 0.703 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.523491e-01 | 0.817 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.825169e-01 | 0.739 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.877191e-01 | 0.726 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.498361e-01 | 0.602 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.530103e-01 | 0.815 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.266367e-01 | 0.645 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.874048e-01 | 0.727 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.852853e-01 | 0.732 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.528825e-01 | 0.597 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.439419e-01 | 0.842 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.874048e-01 | 0.727 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.321853e-01 | 0.634 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.124374e-01 | 0.673 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.321853e-01 | 0.634 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.908650e-01 | 0.719 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.745561e-01 | 0.758 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.565858e-01 | 0.591 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.313111e-01 | 0.636 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 2.647667e-01 | 0.577 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.333991e-01 | 0.632 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.726842e-01 | 0.564 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.434658e-01 | 0.843 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.369946e-01 | 0.863 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.488976e-01 | 0.827 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.852853e-01 | 0.732 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.523491e-01 | 0.817 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.124374e-01 | 0.673 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.446760e-01 | 0.611 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.890279e-01 | 0.723 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.656799e-01 | 0.781 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.313111e-01 | 0.636 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.031480e-01 | 0.692 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.143051e-01 | 0.669 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.669614e-01 | 0.777 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.143051e-01 | 0.669 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.266367e-01 | 0.645 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.657572e-01 | 0.576 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.775743e-01 | 0.751 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.432691e-01 | 0.844 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.740212e-01 | 0.562 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.748569e-01 | 0.561 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.748569e-01 | 0.561 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.749194e-01 | 0.561 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.749194e-01 | 0.561 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.749194e-01 | 0.561 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.749194e-01 | 0.561 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.749194e-01 | 0.561 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.749194e-01 | 0.561 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.749194e-01 | 0.561 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.774679e-01 | 0.557 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.824153e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.824153e-01 | 0.549 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.824153e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.824153e-01 | 0.549 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.824153e-01 | 0.549 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.838686e-01 | 0.547 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.840230e-01 | 0.547 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.840230e-01 | 0.547 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.840230e-01 | 0.547 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.840230e-01 | 0.547 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.844572e-01 | 0.546 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.902665e-01 | 0.537 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.902665e-01 | 0.537 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.927353e-01 | 0.534 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.927353e-01 | 0.534 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.927353e-01 | 0.534 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.927353e-01 | 0.534 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.936923e-01 | 0.532 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.941146e-01 | 0.531 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 2.954047e-01 | 0.530 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.960065e-01 | 0.529 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.982242e-01 | 0.525 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.982242e-01 | 0.525 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.982242e-01 | 0.525 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 2.982242e-01 | 0.525 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.982242e-01 | 0.525 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 2.982242e-01 | 0.525 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 2.982242e-01 | 0.525 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.982242e-01 | 0.525 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.982242e-01 | 0.525 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.982242e-01 | 0.525 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.994554e-01 | 0.524 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.994554e-01 | 0.524 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.994554e-01 | 0.524 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.014402e-01 | 0.521 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.052485e-01 | 0.515 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.052485e-01 | 0.515 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.052485e-01 | 0.515 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.052485e-01 | 0.515 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.052485e-01 | 0.515 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.058482e-01 | 0.514 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.078993e-01 | 0.512 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.078993e-01 | 0.512 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.078993e-01 | 0.512 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.078993e-01 | 0.512 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.082545e-01 | 0.511 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.129688e-01 | 0.504 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.149071e-01 | 0.502 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.175264e-01 | 0.498 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.190158e-01 | 0.496 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.190158e-01 | 0.496 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.198460e-01 | 0.495 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.215717e-01 | 0.493 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.222357e-01 | 0.492 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.240973e-01 | 0.489 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.240973e-01 | 0.489 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.240973e-01 | 0.489 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.240973e-01 | 0.489 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.281321e-01 | 0.484 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.314302e-01 | 0.480 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.314302e-01 | 0.480 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.314302e-01 | 0.480 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.314302e-01 | 0.480 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.314302e-01 | 0.480 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 3.314302e-01 | 0.480 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.314302e-01 | 0.480 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.314302e-01 | 0.480 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.314302e-01 | 0.480 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.333204e-01 | 0.477 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.333204e-01 | 0.477 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.333204e-01 | 0.477 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.367079e-01 | 0.473 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.374070e-01 | 0.472 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.374070e-01 | 0.472 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.374070e-01 | 0.472 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.374070e-01 | 0.472 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.374490e-01 | 0.472 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.487382e-01 | 0.458 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.487382e-01 | 0.458 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.532255e-01 | 0.452 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.533249e-01 | 0.452 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.537290e-01 | 0.451 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.544760e-01 | 0.450 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.544760e-01 | 0.450 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.544760e-01 | 0.450 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.582184e-01 | 0.446 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.618006e-01 | 0.442 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.641750e-01 | 0.439 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.641750e-01 | 0.439 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.641750e-01 | 0.439 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.641750e-01 | 0.439 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.641750e-01 | 0.439 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.657204e-01 | 0.437 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.657204e-01 | 0.437 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.657204e-01 | 0.437 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.657204e-01 | 0.437 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.657204e-01 | 0.437 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.657204e-01 | 0.437 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.657204e-01 | 0.437 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.657204e-01 | 0.437 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.692967e-01 | 0.433 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.705708e-01 | 0.431 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.718265e-01 | 0.430 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.732808e-01 | 0.428 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.732808e-01 | 0.428 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.732808e-01 | 0.428 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.738733e-01 | 0.427 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.741365e-01 | 0.427 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.741365e-01 | 0.427 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.782417e-01 | 0.422 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.835825e-01 | 0.416 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.838665e-01 | 0.416 | 1 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.852944e-01 | 0.414 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.900843e-01 | 0.409 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.962876e-01 | 0.402 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.962876e-01 | 0.402 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.962876e-01 | 0.402 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.962876e-01 | 0.402 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.962876e-01 | 0.402 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.962876e-01 | 0.402 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.962876e-01 | 0.402 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.976369e-01 | 0.401 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.976369e-01 | 0.401 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.976369e-01 | 0.401 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.976369e-01 | 0.401 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.976369e-01 | 0.401 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.976369e-01 | 0.401 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.976369e-01 | 0.401 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.983381e-01 | 0.400 | 1 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.012912e-01 | 0.397 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.012912e-01 | 0.397 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.078508e-01 | 0.389 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.078508e-01 | 0.389 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.142902e-01 | 0.383 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.147332e-01 | 0.382 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.209320e-01 | 0.376 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.209320e-01 | 0.376 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.209320e-01 | 0.376 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.209320e-01 | 0.376 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.209320e-01 | 0.376 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.209320e-01 | 0.376 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.209320e-01 | 0.376 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.209320e-01 | 0.376 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.209320e-01 | 0.376 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.209320e-01 | 0.376 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.217273e-01 | 0.375 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.217273e-01 | 0.375 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.217273e-01 | 0.375 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.255459e-01 | 0.371 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.255459e-01 | 0.371 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.255459e-01 | 0.371 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.276302e-01 | 0.369 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.276302e-01 | 0.369 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.276302e-01 | 0.369 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.276302e-01 | 0.369 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.276302e-01 | 0.369 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.276302e-01 | 0.369 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.276302e-01 | 0.369 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.276302e-01 | 0.369 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 4.276302e-01 | 0.369 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.299512e-01 | 0.367 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.316921e-01 | 0.365 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.348239e-01 | 0.362 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.389417e-01 | 0.358 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.415966e-01 | 0.355 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.415966e-01 | 0.355 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.431373e-01 | 0.353 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.454815e-01 | 0.351 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.454815e-01 | 0.351 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.503330e-01 | 0.346 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.534711e-01 | 0.343 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.580934e-01 | 0.339 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.580934e-01 | 0.339 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.580934e-01 | 0.339 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.605945e-01 | 0.337 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.605945e-01 | 0.337 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.605945e-01 | 0.337 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.688374e-01 | 0.329 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.688374e-01 | 0.329 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.688374e-01 | 0.329 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.688374e-01 | 0.329 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.691458e-01 | 0.329 | 1 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.713407e-01 | 0.327 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.713407e-01 | 0.327 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.713407e-01 | 0.327 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.713407e-01 | 0.327 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.713407e-01 | 0.327 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.713407e-01 | 0.327 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.713407e-01 | 0.327 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.713407e-01 | 0.327 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.713407e-01 | 0.327 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.713407e-01 | 0.327 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 4.713407e-01 | 0.327 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.713407e-01 | 0.327 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.713407e-01 | 0.327 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.713407e-01 | 0.327 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 4.713407e-01 | 0.327 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.724867e-01 | 0.326 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.743711e-01 | 0.324 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.743711e-01 | 0.324 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.791322e-01 | 0.320 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.822831e-01 | 0.317 | 1 | 1 |
| Iron uptake and transport | R-HSA-917937 | 4.837922e-01 | 0.315 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.850334e-01 | 0.314 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.875930e-01 | 0.312 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.875930e-01 | 0.312 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.875930e-01 | 0.312 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.875930e-01 | 0.312 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.917408e-01 | 0.308 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.937508e-01 | 0.306 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.937508e-01 | 0.306 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.949941e-01 | 0.305 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.949941e-01 | 0.305 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.965325e-01 | 0.304 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.982123e-01 | 0.303 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.985041e-01 | 0.302 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.096147e-01 | 0.293 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.098943e-01 | 0.293 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.111907e-01 | 0.291 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.118855e-01 | 0.291 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.160659e-01 | 0.287 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.160659e-01 | 0.287 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.160659e-01 | 0.287 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.160659e-01 | 0.287 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.160659e-01 | 0.287 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.160659e-01 | 0.287 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.160659e-01 | 0.287 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.160659e-01 | 0.287 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 5.160659e-01 | 0.287 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.173640e-01 | 0.286 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.173640e-01 | 0.286 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.173640e-01 | 0.286 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.173640e-01 | 0.286 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.173640e-01 | 0.286 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.173640e-01 | 0.286 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.173640e-01 | 0.286 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.173640e-01 | 0.286 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.173640e-01 | 0.286 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.173640e-01 | 0.286 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.173640e-01 | 0.286 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.173640e-01 | 0.286 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.173640e-01 | 0.286 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 5.173640e-01 | 0.286 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.173640e-01 | 0.286 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.173640e-01 | 0.286 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.173640e-01 | 0.286 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.232918e-01 | 0.281 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.285405e-01 | 0.277 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.315575e-01 | 0.274 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.328266e-01 | 0.273 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.328266e-01 | 0.273 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.328266e-01 | 0.273 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.360107e-01 | 0.271 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.360107e-01 | 0.271 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.360107e-01 | 0.271 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.360107e-01 | 0.271 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.384727e-01 | 0.269 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.384727e-01 | 0.269 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.434673e-01 | 0.265 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.434673e-01 | 0.265 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.434673e-01 | 0.265 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.434673e-01 | 0.265 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.434673e-01 | 0.265 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 5.434673e-01 | 0.265 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.442904e-01 | 0.264 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.449385e-01 | 0.264 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.512384e-01 | 0.259 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.527970e-01 | 0.257 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.532889e-01 | 0.257 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.532889e-01 | 0.257 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.593831e-01 | 0.252 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.593831e-01 | 0.252 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.593831e-01 | 0.252 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.593831e-01 | 0.252 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.593831e-01 | 0.252 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.593831e-01 | 0.252 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.593831e-01 | 0.252 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.593831e-01 | 0.252 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 5.593831e-01 | 0.252 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.593831e-01 | 0.252 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.610609e-01 | 0.251 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.656250e-01 | 0.247 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.697681e-01 | 0.244 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.697681e-01 | 0.244 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.697681e-01 | 0.244 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.697681e-01 | 0.244 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.768908e-01 | 0.239 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.779997e-01 | 0.238 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.779997e-01 | 0.238 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.819044e-01 | 0.235 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.830644e-01 | 0.234 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.854923e-01 | 0.232 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.854923e-01 | 0.232 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.949521e-01 | 0.226 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.949521e-01 | 0.226 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.949521e-01 | 0.226 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.949521e-01 | 0.226 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.977462e-01 | 0.223 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.977462e-01 | 0.223 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.977462e-01 | 0.223 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.977462e-01 | 0.223 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.977462e-01 | 0.223 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.977462e-01 | 0.223 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.977462e-01 | 0.223 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.977462e-01 | 0.223 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.977462e-01 | 0.223 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.977462e-01 | 0.223 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.977462e-01 | 0.223 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.980748e-01 | 0.223 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.988614e-01 | 0.223 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.026477e-01 | 0.220 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.026477e-01 | 0.220 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.037038e-01 | 0.219 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.049120e-01 | 0.218 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.076151e-01 | 0.216 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.106190e-01 | 0.214 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.126366e-01 | 0.213 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.150995e-01 | 0.211 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.175136e-01 | 0.209 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.175136e-01 | 0.209 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.175851e-01 | 0.209 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.190144e-01 | 0.208 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.190144e-01 | 0.208 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.190144e-01 | 0.208 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.190144e-01 | 0.208 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.190144e-01 | 0.208 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.190144e-01 | 0.208 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.190144e-01 | 0.208 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.190144e-01 | 0.208 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.193658e-01 | 0.208 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.224113e-01 | 0.206 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.261413e-01 | 0.203 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.327713e-01 | 0.199 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.327713e-01 | 0.199 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.327713e-01 | 0.199 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.327713e-01 | 0.199 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.327713e-01 | 0.199 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.327713e-01 | 0.199 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.327713e-01 | 0.199 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.327713e-01 | 0.199 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.327713e-01 | 0.199 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.327713e-01 | 0.199 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.327713e-01 | 0.199 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.327713e-01 | 0.199 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 6.327713e-01 | 0.199 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.327713e-01 | 0.199 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.356349e-01 | 0.197 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.356349e-01 | 0.197 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.363046e-01 | 0.196 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.363046e-01 | 0.196 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.363046e-01 | 0.196 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.363046e-01 | 0.196 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.393755e-01 | 0.194 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.393755e-01 | 0.194 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.419595e-01 | 0.192 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.419595e-01 | 0.192 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.419595e-01 | 0.192 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.419595e-01 | 0.192 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.514461e-01 | 0.186 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.514461e-01 | 0.186 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.520510e-01 | 0.186 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.523239e-01 | 0.186 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.542292e-01 | 0.184 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.544404e-01 | 0.184 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.568934e-01 | 0.183 | 1 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.620151e-01 | 0.179 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.637994e-01 | 0.178 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.637994e-01 | 0.178 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.647486e-01 | 0.177 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.647486e-01 | 0.177 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.647486e-01 | 0.177 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.647486e-01 | 0.177 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.647486e-01 | 0.177 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.647486e-01 | 0.177 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.647486e-01 | 0.177 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.647486e-01 | 0.177 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.647486e-01 | 0.177 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.649090e-01 | 0.177 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.649090e-01 | 0.177 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.698062e-01 | 0.174 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.719175e-01 | 0.173 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.793678e-01 | 0.168 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.797180e-01 | 0.168 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.845526e-01 | 0.165 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.845526e-01 | 0.165 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.845526e-01 | 0.165 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.845526e-01 | 0.165 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.855367e-01 | 0.164 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.887358e-01 | 0.162 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.915629e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.924270e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.924270e-01 | 0.160 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.939431e-01 | 0.159 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.939431e-01 | 0.159 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.939431e-01 | 0.159 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.939431e-01 | 0.159 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.939431e-01 | 0.159 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.939431e-01 | 0.159 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.939431e-01 | 0.159 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.939431e-01 | 0.159 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.939431e-01 | 0.159 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.960743e-01 | 0.157 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.001891e-01 | 0.155 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.042427e-01 | 0.152 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.042427e-01 | 0.152 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.042427e-01 | 0.152 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.042864e-01 | 0.152 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.044960e-01 | 0.152 | 1 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.048981e-01 | 0.152 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.048981e-01 | 0.152 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.048981e-01 | 0.152 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.204101e-01 | 0.142 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.204101e-01 | 0.142 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.204101e-01 | 0.142 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.204101e-01 | 0.142 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.204101e-01 | 0.142 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.205968e-01 | 0.142 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.205968e-01 | 0.142 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.205968e-01 | 0.142 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.205968e-01 | 0.142 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.205968e-01 | 0.142 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.205968e-01 | 0.142 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.205968e-01 | 0.142 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.205968e-01 | 0.142 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.205968e-01 | 0.142 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.205968e-01 | 0.142 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.205968e-01 | 0.142 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.205968e-01 | 0.142 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.208648e-01 | 0.142 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.228974e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.228974e-01 | 0.141 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.228974e-01 | 0.141 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.228974e-01 | 0.141 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.228974e-01 | 0.141 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.269833e-01 | 0.138 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.286215e-01 | 0.137 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.286215e-01 | 0.137 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.286919e-01 | 0.137 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 7.352798e-01 | 0.134 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.352798e-01 | 0.134 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.352798e-01 | 0.134 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.360305e-01 | 0.133 | 1 | 1 |
| tRNA processing | R-HSA-72306 | 7.368238e-01 | 0.133 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.405477e-01 | 0.130 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.405477e-01 | 0.130 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 7.405477e-01 | 0.130 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.405477e-01 | 0.130 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.429090e-01 | 0.129 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.437998e-01 | 0.129 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.449308e-01 | 0.128 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.449308e-01 | 0.128 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.449308e-01 | 0.128 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.449308e-01 | 0.128 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.449308e-01 | 0.128 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.449308e-01 | 0.128 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.449308e-01 | 0.128 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.449308e-01 | 0.128 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.485475e-01 | 0.126 | 1 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.495170e-01 | 0.125 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.495170e-01 | 0.125 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.572271e-01 | 0.121 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.572271e-01 | 0.121 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.572271e-01 | 0.121 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.572271e-01 | 0.121 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.572271e-01 | 0.121 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.622486e-01 | 0.118 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.663334e-01 | 0.116 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.671468e-01 | 0.115 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.671468e-01 | 0.115 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.671468e-01 | 0.115 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.671468e-01 | 0.115 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 7.671468e-01 | 0.115 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.671468e-01 | 0.115 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.671468e-01 | 0.115 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.726486e-01 | 0.112 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.728650e-01 | 0.112 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.729706e-01 | 0.112 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.729706e-01 | 0.112 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.729706e-01 | 0.112 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.729706e-01 | 0.112 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.729706e-01 | 0.112 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.729706e-01 | 0.112 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.745654e-01 | 0.111 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.761425e-01 | 0.110 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.874290e-01 | 0.104 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.874290e-01 | 0.104 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.874290e-01 | 0.104 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.874290e-01 | 0.104 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.874290e-01 | 0.104 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.878148e-01 | 0.104 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.878148e-01 | 0.104 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.878148e-01 | 0.104 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.878148e-01 | 0.104 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.883488e-01 | 0.103 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.885585e-01 | 0.103 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.933656e-01 | 0.101 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.003970e-01 | 0.097 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.003970e-01 | 0.097 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.017969e-01 | 0.096 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.017969e-01 | 0.096 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.017969e-01 | 0.096 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.017969e-01 | 0.096 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.017969e-01 | 0.096 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.017969e-01 | 0.096 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.048120e-01 | 0.094 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.059457e-01 | 0.094 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.059457e-01 | 0.094 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.059457e-01 | 0.094 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.059457e-01 | 0.094 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.059457e-01 | 0.094 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.059457e-01 | 0.094 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.059457e-01 | 0.094 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.059457e-01 | 0.094 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.059457e-01 | 0.094 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.059457e-01 | 0.094 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.059457e-01 | 0.094 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.059457e-01 | 0.094 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.116744e-01 | 0.091 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.149543e-01 | 0.089 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.149543e-01 | 0.089 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.149543e-01 | 0.089 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.149543e-01 | 0.089 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.149543e-01 | 0.089 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.189027e-01 | 0.087 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.224077e-01 | 0.085 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.224077e-01 | 0.085 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.228505e-01 | 0.085 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.228505e-01 | 0.085 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.228505e-01 | 0.085 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.228505e-01 | 0.085 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.228505e-01 | 0.085 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.228505e-01 | 0.085 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.228505e-01 | 0.085 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.241268e-01 | 0.084 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.272239e-01 | 0.082 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.272239e-01 | 0.082 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.273246e-01 | 0.082 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.273246e-01 | 0.082 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.273246e-01 | 0.082 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.273246e-01 | 0.082 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.298449e-01 | 0.081 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.334627e-01 | 0.079 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.334627e-01 | 0.079 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.365870e-01 | 0.077 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.382835e-01 | 0.077 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.382835e-01 | 0.077 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.382835e-01 | 0.077 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.382835e-01 | 0.077 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.382835e-01 | 0.077 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.382835e-01 | 0.077 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.382835e-01 | 0.077 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.389450e-01 | 0.076 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.389450e-01 | 0.076 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.389450e-01 | 0.076 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.389450e-01 | 0.076 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.389450e-01 | 0.076 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.442201e-01 | 0.074 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.442201e-01 | 0.074 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.442201e-01 | 0.074 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.498523e-01 | 0.071 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.498523e-01 | 0.071 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.519632e-01 | 0.070 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.523728e-01 | 0.069 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.523728e-01 | 0.069 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.523728e-01 | 0.069 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.523728e-01 | 0.069 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.523728e-01 | 0.069 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.523728e-01 | 0.069 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.537560e-01 | 0.069 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.591457e-01 | 0.066 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.600825e-01 | 0.065 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.600825e-01 | 0.065 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.602544e-01 | 0.065 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.652354e-01 | 0.063 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.652354e-01 | 0.063 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.652354e-01 | 0.063 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.652354e-01 | 0.063 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.683254e-01 | 0.061 | 1 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.685349e-01 | 0.061 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.685349e-01 | 0.061 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.696708e-01 | 0.061 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.700438e-01 | 0.060 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.746133e-01 | 0.058 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.763792e-01 | 0.057 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.769780e-01 | 0.057 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 8.769780e-01 | 0.057 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.769780e-01 | 0.057 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.769780e-01 | 0.057 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.783973e-01 | 0.056 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.786512e-01 | 0.056 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.786512e-01 | 0.056 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.786512e-01 | 0.056 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.796273e-01 | 0.056 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.796273e-01 | 0.056 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.838052e-01 | 0.054 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.870569e-01 | 0.052 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.870569e-01 | 0.052 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.870569e-01 | 0.052 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.870569e-01 | 0.052 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.870569e-01 | 0.052 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.870569e-01 | 0.052 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.870569e-01 | 0.052 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.876981e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.876981e-01 | 0.052 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.876981e-01 | 0.052 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 8.876981e-01 | 0.052 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.876981e-01 | 0.052 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.881377e-01 | 0.052 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.890117e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.949198e-01 | 0.048 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.949198e-01 | 0.048 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.949198e-01 | 0.048 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.949198e-01 | 0.048 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.963495e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.974730e-01 | 0.047 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.974846e-01 | 0.047 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.974846e-01 | 0.047 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.974846e-01 | 0.047 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.974846e-01 | 0.047 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.974846e-01 | 0.047 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.974846e-01 | 0.047 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.022708e-01 | 0.045 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.037492e-01 | 0.044 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.041193e-01 | 0.044 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.064188e-01 | 0.043 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.064188e-01 | 0.043 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.064188e-01 | 0.043 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.064188e-01 | 0.043 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.064188e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.064188e-01 | 0.043 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.067026e-01 | 0.043 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.074478e-01 | 0.042 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.078039e-01 | 0.042 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.106255e-01 | 0.041 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.130526e-01 | 0.040 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.145748e-01 | 0.039 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.145748e-01 | 0.039 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.152696e-01 | 0.038 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.155532e-01 | 0.038 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.161406e-01 | 0.038 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.215400e-01 | 0.035 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.215400e-01 | 0.035 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.215400e-01 | 0.035 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.220205e-01 | 0.035 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.220205e-01 | 0.035 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.220205e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.231433e-01 | 0.035 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.271252e-01 | 0.033 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.271252e-01 | 0.033 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.271252e-01 | 0.033 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.271252e-01 | 0.033 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.288176e-01 | 0.032 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.288176e-01 | 0.032 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.288176e-01 | 0.032 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.288176e-01 | 0.032 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.288176e-01 | 0.032 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.288176e-01 | 0.032 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.288176e-01 | 0.032 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.350226e-01 | 0.029 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.350226e-01 | 0.029 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.350226e-01 | 0.029 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.362103e-01 | 0.029 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.371876e-01 | 0.028 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.399382e-01 | 0.027 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.406295e-01 | 0.027 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.406870e-01 | 0.027 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.406870e-01 | 0.027 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.406870e-01 | 0.027 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.406870e-01 | 0.027 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.406870e-01 | 0.027 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.417103e-01 | 0.026 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.417103e-01 | 0.026 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.417103e-01 | 0.026 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.419684e-01 | 0.026 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.426867e-01 | 0.026 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.426867e-01 | 0.026 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.426867e-01 | 0.026 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.458580e-01 | 0.024 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.458580e-01 | 0.024 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.458580e-01 | 0.024 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.458580e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.458580e-01 | 0.024 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.458580e-01 | 0.024 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.463638e-01 | 0.024 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.463638e-01 | 0.024 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.463638e-01 | 0.024 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.498204e-01 | 0.022 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.505784e-01 | 0.022 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.505784e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.505784e-01 | 0.022 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.528965e-01 | 0.021 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.530683e-01 | 0.021 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.548875e-01 | 0.020 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.548875e-01 | 0.020 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.548875e-01 | 0.020 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.548875e-01 | 0.020 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.548875e-01 | 0.020 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.548875e-01 | 0.020 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.568854e-01 | 0.019 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.568854e-01 | 0.019 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.581844e-01 | 0.019 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.588212e-01 | 0.018 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.588212e-01 | 0.018 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.588212e-01 | 0.018 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.588212e-01 | 0.018 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.617082e-01 | 0.017 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.617082e-01 | 0.017 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.617830e-01 | 0.017 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.624120e-01 | 0.017 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.624120e-01 | 0.017 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.641928e-01 | 0.016 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.656899e-01 | 0.015 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.657011e-01 | 0.015 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.665576e-01 | 0.015 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.671999e-01 | 0.014 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.686822e-01 | 0.014 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.687744e-01 | 0.014 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.714136e-01 | 0.013 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.714136e-01 | 0.013 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.727688e-01 | 0.012 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.727979e-01 | 0.012 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.731575e-01 | 0.012 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.739070e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.746203e-01 | 0.011 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.746203e-01 | 0.011 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.763263e-01 | 0.010 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.779229e-01 | 0.010 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.784198e-01 | 0.009 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.790706e-01 | 0.009 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.801571e-01 | 0.009 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.801571e-01 | 0.009 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.801571e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.808135e-01 | 0.008 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.815370e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.818883e-01 | 0.008 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.818883e-01 | 0.008 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.818883e-01 | 0.008 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.823422e-01 | 0.008 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.829271e-01 | 0.007 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.829411e-01 | 0.007 | 1 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.833865e-01 | 0.007 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.834685e-01 | 0.007 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.834685e-01 | 0.007 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.840047e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.842152e-01 | 0.007 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.843911e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.849109e-01 | 0.007 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.854087e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.862276e-01 | 0.006 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.862276e-01 | 0.006 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.874294e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.895278e-01 | 0.005 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.899879e-01 | 0.004 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.904418e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.912761e-01 | 0.004 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.912761e-01 | 0.004 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.912761e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.916216e-01 | 0.004 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.917904e-01 | 0.004 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.918780e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.933671e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.933671e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.939172e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.939380e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.939462e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.949572e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.955693e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.955929e-01 | 0.002 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.961104e-01 | 0.002 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.962515e-01 | 0.002 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.965011e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.965435e-01 | 0.002 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.971731e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.972918e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.973239e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.973402e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.979782e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.979782e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.981548e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.981548e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.984143e-01 | 0.001 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.984632e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.985975e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.985975e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.986080e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.988070e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.991898e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.993054e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.993830e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.993848e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.993848e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.994791e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.996104e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996104e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996468e-01 | 0.000 | 1 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.996568e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997181e-01 | 0.000 | 1 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997750e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998092e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998148e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998437e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998518e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998866e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999028e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999028e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999083e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999179e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999305e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999333e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999431e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999507e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999636e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999687e-01 | 0.000 | 1 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999714e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999732e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999757e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999767e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999790e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999790e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999869e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999870e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999894e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999913e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999925e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999937e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999953e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999970e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999972e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |